{"cells":[{"cell_type":"markdown","metadata":{"id":"_RKAqDaK9cVS"},"source":["# Neural Baseline for NER with LSTM\n","\n","This notebook runs the `lstm.py` script for training a neural baseline model for named entity recognition using LSTM.\n"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"JaU9iFv09cVT"},"outputs":[],"source":["%pip install wandb\n","import wandb\n","wandb.login()"]},{"cell_type":"code","source":["dir_path = \"/content/drive/Othercomputers/Mein Computer/dl-nlp_project_named-entity-recognition/\"\n","train_path = dir_path + \"data/train.json\"\n","test_path = dir_path + \"data/test.json\""],"metadata":{"id":"_EHxEwZ4Tf6M","executionInfo":{"status":"ok","timestamp":1693932127713,"user_tz":-120,"elapsed":647,"user":{"displayName":"Luis Klocke","userId":"15052051274443195697"}}},"execution_count":7,"outputs":[]},{"cell_type":"code","execution_count":8,"metadata":{"id":"xCL7WsjO9cVT","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1693932133710,"user_tz":-120,"elapsed":4143,"user":{"displayName":"Luis Klocke","userId":"15052051274443195697"}},"outputId":"5e542209-bbd6-42fc-c6bd-db93d84e7879"},"outputs":[{"output_type":"stream","name":"stdout","text":["Mounted at /content/drive\n"]}],"source":["from google.colab import drive\n","drive.mount('/content/drive', force_remount=True)"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"Sr2PBDQt9cVU"},"outputs":[],"source":["lstm_path = \"/content/drive/Othercomputers/Mein Computer/dl-nlp_project_named-entity-recognition/lstm.py\"\n","%run \"{lstm_path}\" --train_path \"{train_path}\" --test_path \"{test_path}\""]},{"cell_type":"code","source":["feed_forward_path = \"/content/drive/Othercomputers/Mein Computer/dl-nlp_project_named-entity-recognition/feed_forward_NN.py\"\n","%run \"{feed_forward_path}\" --train_path \"{train_path}\" --test_path \"{test_path}\""],"metadata":{"id":"iu_iZ27rTW_m"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["rnn_path = \"rnn.py\"\n","%run \"{rnn_path}\" --train_path \"{train_path}\" --test_path \"{test_path}\""],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":506},"id":"xn8Nxppp8yrk","executionInfo":{"status":"ok","timestamp":1693932143288,"user_tz":-120,"elapsed":6535,"user":{"displayName":"Luis Klocke","userId":"15052051274443195697"}},"outputId":"03b52d1b-75c9-40fa-a15d-ccd13d2f14f7"},"execution_count":9,"outputs":[{"output_type":"stream","name":"stdout","text":["torch.Size([32, 181])\n","{0: '<PAD>', 1: '<UNK>', 2: 'Clin', 3: 'Ther', 4: '.', 5: '2006', 6: 'Oct', 7: ';', 8: '28', 9: '(', 10: '10', 11: ')', 12: ':', 13: '1556', 14: '-', 15: '68', 16: 'Efficacy', 17: 'and', 18: 'safety', 19: 'of', 20: 'the', 21: 'dipeptidyl', 22: 'peptidase', 23: '4', 24: 'inhibitor', 25: 'sitagliptin', 26: 'added', 27: 'to', 28: 'ongoing', 29: 'pioglitazone', 30: 'therapy', 31: 'in', 32: 'patients', 33: 'with', 34: 'type', 35: '2', 36: 'diabetes', 37: 'a', 38: '24', 39: 'week', 40: ',', 41: 'multicenter', 42: 'randomized', 43: 'double', 44: 'blind', 45: 'placebo', 46: 'controlled', 47: 'parallel', 48: 'group', 49: 'study', 50: 'Rosenstock', 51: 'J', 52: '1', 53: 'Brazg', 54: 'R', 55: 'Andryuk', 56: 'PJ', 57: 'Lu', 58: 'K', 59: 'Stein', 60: 'P', 61: 'Sitagliptin', 62: 'Study', 63: '019', 64: 'Group', 65: 'Author', 66: 'information', 67: 'Dallas', 68: 'Diabetes', 69: 'Endocrine', 70: 'Center', 71: 'Texas', 72: 'USA', 73: 'OBJECTIVE', 74: 'The', 75: 'efficacy', 76: 'tolerability', 77: 'were', 78: 'assessed', 79: 'inadequate', 80: 'glycemic', 81: 'control', 82: 'glycosylated', 83: 'hemoglobin', 84: '[', 85: 'HbA', 86: '1c', 87: ']', 88: '>', 89: 'or', 90: '=', 91: '7', 92: '%', 93: '<', 94: 'while', 95: 'receiving', 96: 'stable', 97: 'dose', 98: 'METHODS', 99: 'This', 100: 'was', 101: 'aged', 102: '18', 103: 'years', 104: 'ClinicalTrials', 105: 'gov', 106: 'NCT00086502', 107: 'At', 108: 'screening', 109: 'all', 110: 'began', 111: 'diet', 112: '/', 113: 'exercise', 114: 'program', 115: 'that', 116: 'continued', 117: 'throughout', 118: 'period', 119: 'Patients', 120: 'taking', 121: 'antihyperglycemic', 122: 'other', 123: 'than', 124: 'underwent', 125: 'washout', 126: 'this', 127: 'entered', 128: 'an', 129: '8', 130: '14', 131: 'open', 132: 'label', 133: 'titration', 134: 'stabilization', 135: 'at', 136: 'end', 137: 'single', 138: 'run', 139: 'total', 140: 'duration', 141: 'up', 142: '21', 143: 'weeks', 144: 'who', 145: 'had', 146: 'been', 147: 'monotherapy', 148: '30', 149: '45', 150: 'mg', 151: 'd', 152: 'directly', 153: 'Thus', 154: 'time', 155: 'randomization', 156: 'ratio', 157: 'receive', 158: '100', 159: 'once', 160: 'daily', 161: 'for', 162: 'primary', 163: 'point', 164: 'change', 165: 'from', 166: 'baseline', 167: 'Secondary', 168: 'points', 169: 'included', 170: 'fasting', 171: 'plasma', 172: 'glucose', 173: 'FPG', 174: 'insulin', 175: 'proinsulin', 176: 'Homeostasis', 177: 'Model', 178: 'Assessment', 179: 'beta', 180: 'cell', 181: 'function', 182: 'resistance', 183: 'indexes', 184: 'Quantitative', 185: 'Insulin', 186: 'Sensitivity', 187: 'Check', 188: 'Index', 189: 'percent', 190: 'changes', 191: 'selected', 192: 'lipid', 193: 'parameters', 194: 'proportion', 195: 'meeting', 196: 'American', 197: 'Association', 198: 'goal', 199: '0', 200: 'requiring', 201: 'metformin', 202: 'rescue', 203: 'initiation', 204: 'RESULTS', 205: 'One', 206: 'hundred', 207: 'seventy', 208: 'five', 209: '178', 210: 'mean', 211: 'SD', 212: 'HbAlc', 213: 'value', 214: 'After', 215: 'associated', 216: 'significant', 217: 'reductions', 218: 'compared', 219: 'between', 220: 'treatment', 221: 'difference', 222: 'least', 223: 'squares', 224: 'LS', 225: '70', 226: '95', 227: 'CI', 228: '85', 229: '54', 230: '001', 231: '17', 232: 'dL', 233: '3', 234: '11', 235: 'Mean', 236: 'values', 237: '9', 238: 'respective', 239: 'groups', 240: 'proportions', 241: 'reaching', 242: 'target', 243: '23', 244: 'Significant', 245: 'serum', 246: 'levels', 247: 'seen', 248: 'both', 249: '01', 250: 'generally', 251: 'well', 252: 'tolerated', 253: 'no', 254: 'increased', 255: 'risk', 256: 'hypoglycemia', 257: 'vs', 258: 'respectively', 259: 'DOI', 260: '1016', 261: 'j', 262: 'clinthera', 263: '007', 264: 'PMID', 265: '17157112', 266: 'Indexed', 267: 'MEDLINE', 268: 'Care', 269: '2013', 270: 'May', 271: '36', 272: '5', 273: '1304', 274: 'doi', 275: '2337', 276: 'dc12', 277: '0719', 278: 'Epub', 279: '2012', 280: 'Dec', 281: 'Effects', 282: 'versus', 283: 'glipizide', 284: 'on', 285: 'cardiovascular', 286: 'outcomes', 287: 'coronary', 288: 'artery', 289: 'disease', 290: 'Hong', 291: 'Zhang', 292: 'Y', 293: 'Lai', 294: 'S', 295: 'Lv', 296: 'A', 297: 'Su', 298: 'Q', 299: 'Dong', 300: 'Zhou', 301: 'Z', 302: 'Tang', 303: 'W', 304: 'Zhao', 305: 'Cui', 306: 'L', 307: 'Zou', 308: 'D', 309: 'Wang', 310: 'Li', 311: 'H', 312: 'Liu', 313: 'C', 314: 'Wu', 315: 'G', 316: 'Shen', 317: 'Zhu', 318: 'Ning', 319: 'SPREAD', 320: 'DIMCAD', 321: 'Investigators', 322: 'Collaborators', 323: 'Gui', 324: 'M', 325: 'Chen', 326: 'Chi', 327: 'Yan', 328: 'Zhai', 329: 'Yang', 330: 'Fan', 331: 'X', 332: 'Hang', 333: 'Xing', 334: 'Guan', 335: 'F', 336: 'T', 337: 'B', 338: 'Qu', 339: 'Sheng', 340: 'Cheng', 341: 'Xue', 342: 'Luo', 343: 'Yao', 344: 'Yu', 345: 'Jin', 346: 'Shi', 347: 'Feng', 348: 'Ni', 349: 'Gong', 350: 'Shanghai', 351: 'Jiao', 352: 'Tong', 353: 'University', 354: 'School', 355: 'Medicine', 356: 'China', 357: 'Comment', 358: 'Ann', 359: 'Intern', 360: 'Med', 361: 'Apr', 362: '16', 363: '158', 364: 'JC4', 365: '2014', 366: '37', 367: 'e19', 368: '20', 369: 'e21', 370: 'two', 371: 'major', 372: 'classes', 373: 'antidiabetic', 374: 'drugs', 375: 'sulfonylureas', 376: 'may', 377: 'differentially', 378: 'affect', 379: 'macrovascular', 380: 'complications', 381: 'mortality', 382: 'diabetic', 383: 'We', 384: 'long', 385: 'term', 386: 'effects', 387: 'events', 388: 'history', 389: 'CAD', 390: 'RESEARCH', 391: 'DESIGN', 392: 'AND', 393: 'is', 394: 'clinical', 395: 'trial', 396: '304', 397: 'age', 398: '63', 399: 'range', 400: '80', 401: 'enrolled', 402: 'Participants', 403: 'randomly', 404: 'assigned', 405: 'either', 406: 'g', 407: 'times', 408: 'composite', 409: 'recurrent', 410: 'including', 411: 'death', 412: 'cause', 413: 'any', 414: 'nonfatal', 415: 'myocardial', 416: 'infarction', 417: 'stroke', 418: 'arterial', 419: 'revascularization', 420: 'drug', 421: 'administration', 422: 'achieved', 423: 'decrease', 424: 'level', 425: 'glycated', 426: 'median', 427: 'follow', 428: '91', 429: 'participants', 430: 'developed', 431: '103', 432: 'Intention', 433: 'treat', 434: 'analysis', 435: 'showed', 436: 'adjusted', 437: 'hazard', 438: 'HR', 439: '90', 440: '026', 441: 'composites', 442: 'among', 443: 'received', 444: 'secondary', 445: 'adverse', 446: 'not', 447: 'significantly', 448: 'different', 449: 'CONCLUSIONS', 450: 'Treatment', 451: 'substantially', 452: 'reduced', 453: 'Our', 454: 'results', 455: 'indicated', 456: 'potential', 457: 'benefit', 458: 'high', 459: 'PMCID', 460: 'PMC3631843', 461: '23230096', 462: 'Endocr', 463: '2016', 464: 'Aug', 465: '31', 466: '747', 467: '53', 468: '1507', 469: 'endocrj', 470: 'EJ16', 471: '0266', 472: 'Jun', 473: 'Comparative', 474: 'vildagliptin', 475: 'determined', 476: 'by', 477: 'continuous', 478: 'monitoring', 479: 'mellitus', 480: 'Koyanagawa', 481: 'N', 482: 'Miyoshi', 483: 'Ono', 484: 'Nakamura', 485: 'Cho', 486: 'KY', 487: 'Yamamoto', 488: 'Takano', 489: 'Dan', 490: 'Noura', 491: 'Atsumi', 492: 'Division', 493: 'Rheumatology', 494: 'Endocrinology', 495: 'Nephrology', 496: 'Hokkaido', 497: 'Graduate', 498: 'Sapporo', 499: 'Japan', 500: 'inhibitors', 501: 'are', 502: 'effective', 503: 'treating', 504: 'standard', 505: 'doses', 506: 'plus', 507: 'require', 508: 'switching', 509: 'improve', 510: 'blood', 511: 'increasing', 512: 'prospective', 513: 'comparison', 514: '33', 515: '50', 516: 'Seventeen', 517: 'twice', 518: 'evaluated', 519: 'after', 520: 'amplitude', 521: 'excursions', 522: 'MAGE', 523: 'decreased', 524: '13', 525: '±', 526: '35', 527: 'but', 528: 'neither', 529: 'within', 530: 'nor', 531: 'statistically', 532: 'Similarly', 533: 'areas', 534: 'under', 535: 'curve', 536: '≥', 537: '180', 538: 'tended', 539: 'these', 540: 'differences', 541: 'In', 542: 'contrast', 543: 'HbA1c', 544: 'only', 545: '6', 546: 'p', 547: '006', 548: 'Increasing', 549: 'limited', 550: 'improving', 551: 'treated', 552: '27321385', 553: 'Obes', 554: 'Metab', 555: '2007', 556: 'Sep', 557: '733', 558: '26', 559: 'inadequately', 560: 'glimepiride', 561: 'alone', 562: 'Hermansen', 563: 'Kipnes', 564: 'E', 565: 'Fanurik', 566: 'Khatami', 567: '035', 568: 'Aarhus', 569: 'Hospital', 570: 'Denmark', 571: 'AIM', 572: 'To', 573: 'assess', 574: 'highly', 575: 'selective', 576: 'oral', 577: 'DPP', 578: 'glycaemic', 579: 'haemoglobin', 580: 'combination', 581: 'wash', 582: 'off', 583: '+', 584: '441', 585: 'ages', 586: '75', 587: 'addition', 588: 'Of', 589: '212', 590: 'day', 591: '229', 592: '500', 593: 'exceeding', 594: 'pre', 595: 'specified', 596: 'thresholds', 597: 'during', 598: 'provided', 599: 'until', 600: 'Week', 601: 'endpoints', 602: 'h', 603: 'post', 604: 'meal', 605: 'measurements', 606: '34', 607: '74', 608: 'relative', 609: 'subset', 610: '89', 611: 'reduction', 612: '57', 613: 'dl', 614: 'homeostasis', 615: 'model', 616: 'assessment', 617: 'marker', 618: '12', 619: '05', 620: 'tolerance', 621: 'test', 622: 'n', 623: '134', 624: 'prandial', 625: 'PPG', 626: 'although', 627: 'there', 628: 'higher', 629: 'incidence', 630: 'overall', 631: '60', 632: '47', 633: 'related', 634: 'experiences', 635: 'AEs', 636: '15', 637: 'largely', 638: 'because', 639: 'hypoglycaemia', 640: 'Body', 641: 'weight', 642: 'modestly', 643: 'kg', 644: 'improved', 645: 'modest', 646: 'increase', 647: 'body', 648: 'consistent', 649: 'observed', 650: 'degree', 651: 'improvement', 652: '1111', 653: '1463', 654: '1326', 655: '00744', 656: 'x', 657: '17593236', 658: 'Pharmacotherapy', 659: '2015', 660: 'Nov', 661: '983', 662: '1002', 663: 'phar', 664: '1648', 665: 'Effect', 666: 'Acarbose', 667: 'Glycemic', 668: 'Variability', 669: 'Poorly', 670: 'Controlled', 671: 'Type', 672: 'Mellitus', 673: 'Receiving', 674: 'Stable', 675: 'Background', 676: 'Therapy', 677: 'Placebo', 678: 'Trial', 679: 'Derosa', 680: 'Franzetti', 681: 'I', 682: 'Querci', 683: \"'\", 684: 'Angelo', 685: 'Maffioli', 686: 'Department', 687: 'Internal', 688: 'Therapeutics', 689: 'Pavia', 690: 'Fondazione', 691: 'IRCCS', 692: 'Policlinico', 693: 'Matteo', 694: 'Italy', 695: 'Metabolic', 696: 'Pathophysiology', 697: 'Clinical', 698: 'Research', 699: 'Laboratory', 700: 'Molecular', 701: 'Unit', 702: 'Antonio', 703: 'Abate', 704: 'Gallarate', 705: 'Varese', 706: 'Ospedale', 707: 'Pesenti', 708: 'Fenaroli', 709: 'Alzano', 710: 'Lombardo', 711: 'Bergamo', 712: 'PhD', 713: 'Experimental', 714: 'STUDY', 715: 'evaluate', 716: 'effect', 717: 'acarbose', 718: 'variability', 719: 'using', 720: 'system', 721: 'Multicenter', 722: 'SETTING', 723: 'research', 724: 'units', 725: 'three', 726: 'hospitals', 727: 'PATIENTS', 728: 'Fifty', 729: 'dosages', 730: '850', 731: 'months', 732: 'adequately', 733: 'therapies', 734: 'INTERVENTION', 735: 'be', 736: 'their', 737: 'regimen', 738: 'MEASUREMENTS', 739: 'MAIN', 740: 'estimated', 741: 'as', 742: 'MBG', 743: 'area', 744: 'concentration', 745: 'above', 746: 'AUC', 747: 'percentage', 748: 'Intraday', 749: 'deviation', 750: 'overlapping', 751: 'net', 752: 'action', 753: 'Day', 754: 'MODD', 755: '~', 756: 'lower', 757: 'particularly', 758: 'postprandial', 759: 'did', 760: 'differ', 761: 'whereas', 762: '40', 763: 'daytime', 764: 'Moreover', 765: 'changed', 766: 'recorded', 767: 'All', 768: 'mild', 769: 'greater', 770: 'frequency', 771: 'flatulence', 772: 'noted', 773: 'CONCLUSION', 774: 'background', 775: 'intraday', 776: 'especially', 777: 'it', 778: 'interday', 779: '©', 780: 'Publications', 781: 'Inc', 782: '26598090', 783: 'Horm', 784: 'Res', 785: '2003', 786: 'Mar', 787: '189', 788: '96', 789: 'one', 790: 'year', 791: 'randomised', 792: 'multicentre', 793: 'comparing', 794: 'glargine', 795: 'NPH', 796: 'agents', 797: 'Massi', 798: 'Benedetti', 799: 'Humburg', 800: 'Dressler', 801: 'Ziemen', 802: 'Perugia', 803: 'massi', 804: '@', 805: 'unipg', 806: 'AIMS', 807: 'aim', 808: 'compare', 809: 'new', 810: 'acting', 811: 'basal', 812: 'LANTUS', 813: 'human', 814: 'each', 815: 'administered', 816: '570', 817: '52', 818: 'given', 819: 'bedtime', 820: 'Previous', 821: 'There', 822: 'clinically', 823: 'relevant', 824: 'GHb', 825: 'endpoint', 826: '46', 827: '38', 828: '415', 829: 'also', 830: 'subgroup', 831: 'overweight', 832: 'BMI', 833: 'm', 834: '42', 835: '0237', 836: 'Over', 837: 'entire', 838: '41', 839: 'experienced', 840: 'similar', 841: 'symptomatic', 842: 'number', 843: 'reported', 844: 'episode', 845: 'nocturnal', 846: 'those', 847: 'population', 848: '002', 849: '22', 850: '0006', 851: 'Cochran', 852: 'Mantel', 853: 'Haenszel', 854: 'These', 855: 'most', 856: 'pronounced', 857: 'na', 858: 'ï', 859: 've', 860: 'sub', 861: 'treatments', 862: 'demonstrated', 863: 'achieving', 864: 'fewer', 865: 'episodes', 866: '1055', 867: 's', 868: '39080', 869: '12734781', 870: 'Arch', 871: '2009', 872: '169', 873: '616', 874: '25', 875: '1001', 876: 'archinternmed', 877: 'Long', 878: 'metabolism', 879: 'microvascular', 880: 'Kooy', 881: 'de', 882: 'Jager', 883: 'Lehert', 884: 'Bets', 885: 'Wulffel', 886: 'é', 887: 'MG', 888: 'Donker', 889: 'AJ', 890: 'Stehouwer', 891: 'CD', 892: 'Bethesda', 893: 'RA', 894: 'Hoogeveen', 895: 'Netherlands', 896: 'kooy', 897: 'bethesda', 898: 'nl', 899: 'Jul', 900: '151', 901: 'JC1', 902: 'Evid', 903: 'Based', 904: '139', 905: 'Republished', 906: 'Ned', 907: 'Tijdschr', 908: 'Geneeskd', 909: '153', 910: 'BACKGROUND', 911: 'investigated', 912: 'whether', 913: 'hydrochloride', 914: 'has', 915: 'sustained', 916: 'beneficial', 917: 'metabolic', 918: 'cardio', 919: 'vascular', 920: 'DM2', 921: 'studied', 922: '390', 923: 'outpatient', 924: 'clinics', 925: 'Either', 926: 'aggregate', 927: 'morbidity', 928: 'separate', 929: 'scores', 930: 'requirement', 931: 'pressure', 932: 'mass', 933: 'index', 934: 'analyzed', 935: 'Metformin', 936: 'prevented', 937: 'gain', 938: '07', 939: '55', 940: 'where', 941: 'indicates', 942: 'confidence', 943: 'interval', 944: 'despite', 945: 'requirements', 946: '19', 947: 'IU', 948: 'It', 949: 'however', 950: '61', 951: '94', 952: '02', 953: 'which', 954: 'partly', 955: 'explained', 956: 'needed', 957: 'prevent', 958: '66', 959: 'reduce', 960: 'support', 961: 'policy', 962: 'continue', 963: 'introduction', 964: 'patient', 965: 'unless', 966: 'contraindicated', 967: 'Registration', 968: 'Identifier', 969: 'NCT00375388', 970: '19307526', 971: '146', 972: '477', 973: 'adding', 974: 'exenatide', 975: 'thiazolidinedione', 976: 'suboptimally', 977: 'Zinman', 978: 'Hoogwerf', 979: 'BJ', 980: 'Dur', 981: 'á', 982: 'Garc', 983: 'í', 984: 'Milton', 985: 'DR', 986: 'Giaconia', 987: 'JM', 988: 'Kim', 989: 'DD', 990: 'Trautmann', 991: 'ME', 992: 'Brodows', 993: 'RG', 994: 'Samuel', 995: 'Lunenfeld', 996: 'Institute', 997: 'Mount', 998: 'Sinai', 999: 'Toronto', 1000: 'Ontario', 1001: 'Canada', 1002: 'zinman', 1003: 'mshri', 1004: 'ca', 1005: 'Erratum', 1006: '896', 1007: '527', 1008: 'Summary', 1009: 'I18', 1010: 'Exenatide', 1011: 'Thiazolidinediones', 1012: 'TZDs', 1013: 'commonly', 1014: 'used', 1015: 'TZD', 1016: 'conducted', 1017: '2004', 1018: 'August', 1019: '2005', 1020: '49', 1021: 'sites', 1022: 'Spain', 1023: 'United', 1024: 'States', 1025: '233', 1026: '121', 1027: '112', 1028: 'without', 1029: 'SE', 1030: 'A1c', 1031: 'INTERVENTIONS', 1032: 'Subcutaneous', 1033: 'abdominal', 1034: 'injections', 1035: 'microg', 1036: 'outcome', 1037: 'Other', 1038: 'self', 1039: 'monitored', 1040: '98', 1041: '69', 1042: 'mmol', 1043: '{', 1044: '}', 1045: '51', 1046: '88', 1047: 'Sixteen', 1048: 'discontinued', 1049: '48', 1050: 'nausea', 1051: 'mostly', 1052: 'moderate', 1053: 'vomiting', 1054: 'LIMITATIONS', 1055: 'Combinations', 1056: 'tested', 1057: 'relatively', 1058: 'short', 1059: 'Only', 1060: '71', 1061: '86', 1062: 'completed', 1063: 'caused', 1064: 'gastrointestinal', 1065: 'symptoms', 1066: 'more', 1067: 'registration', 1068: 'NCT00099320', 1069: 'For', 1070: 'click', 1071: 'here', 1072: '7326', 1073: '0003', 1074: '4819', 1075: '200704030', 1076: '00003', 1077: '17404349', 1078: '2001', 1079: '631', 1080: 'Basal', 1081: 'HOE', 1082: '901', 1083: 'Schwartz', 1084: 'SL', 1085: 'Clark', 1086: 'CM', 1087: 'Jr', 1088: 'Park', 1089: 'GD', 1090: 'Donley', 1091: 'DW', 1092: 'Edwards', 1093: 'MB', 1094: '75230', 1095: 'juliorosenstock', 1096: 'dallasdiabetes', 1097: 'com', 1098: 'determine', 1099: 'analog', 1100: 'previously', 1101: '518', 1102: 'subjects', 1103: 'regular', 1104: '259', 1105: 'Doses', 1106: 'obtain', 1107: 'l', 1108: 'improvements', 1109: 'intent', 1110: 'means', 1111: '59', 1112: 'average', 1113: 'approximately', 1114: 'Overall', 1115: 'However', 1116: 'phase', 1117: '0136', 1118: 'Subjects', 1119: 'less', 1120: '0007', 1121: 'maintaining', 1122: 'deonstrates', 1123: 'diacare', 1124: '11315821', 1125: '62', 1126: 'Does', 1127: 'bromocriptine', 1128: 'obese', 1129: 'diabetics', 1130: '?', 1131: 'Aminorroaya', 1132: 'Janghorbani', 1133: 'Ramezani', 1134: 'Haghighi', 1135: 'Amini', 1136: 'Isfahan', 1137: 'Metabolism', 1138: 'Medical', 1139: 'Sciences', 1140: 'Health', 1141: 'Services', 1142: 'Iran', 1143: 'aminorroaya', 1144: 'med', 1145: 'mui', 1146: 'ac', 1147: 'ir', 1148: 'Various', 1149: 'hypoglycemic', 1150: 'have', 1151: 'already', 1152: 'normalize', 1153: 'concentrations', 1154: 'they', 1155: 'complete', 1156: 'success', 1157: 'recent', 1158: 'tried', 1159: 'controversial', 1160: 'present', 1161: '32', 1162: 'allocated', 1163: 'first', 1164: 'second', 1165: 'They', 1166: 'uncontrolled', 1167: 'fixed', 1168: 'glibenclamide', 1169: 'its', 1170: 'before', 1171: 'enrolling', 1172: 'HbA1', 1173: 'measured', 1174: 'calculated', 1175: '06', 1176: 'SEM', 1177: 'No', 1178: 'occurred', 1179: 'data', 1180: 'further', 1181: 'contention', 1182: 'improves', 1183: 'mechanism', 1184: 'remains', 1185: '1159', 1186: '000078932', 1187: '15205563', 1188: 'Diabetologia', 1189: '2008', 1190: '408', 1191: '1007', 1192: 's00125', 1193: '0911', 1194: 'Jan', 1195: 'detemir', 1196: 'when', 1197: 'add', 1198: 'lowering', 1199: 'naive', 1200: 'people', 1201: 'Davies', 1202: 'Home', 1203: 'PD', 1204: 'Larsen', 1205: 'Koenen', 1206: 'Schernthaner', 1207: 'City', 1208: '7777', 1209: 'Forest', 1210: 'Lane', 1211: '685', 1212: 'TX', 1213: 'Nat', 1214: 'Pract', 1215: 'Endocrinol', 1216: '490', 1217: 'HYPOTHESIS', 1218: 'multinational', 1219: 'non', 1220: 'inferiority', 1221: 'following', 1222: 'supplementation', 1223: 'analogues', 1224: 'adults', 1225: '582', 1226: 'evening', 1227: 'actively', 1228: 'titrated', 1229: 'An', 1230: 'additional', 1231: 'morning', 1232: 'permitted', 1233: 'if', 1234: 'dinner', 1235: 'PG', 1236: 'Due', 1237: 'labelling', 1238: 'restrictions', 1239: 'allowed', 1240: 'Baseline', 1241: 'NS', 1242: 'With', 1243: 'dosing', 1244: 'Within', 1245: 'participant', 1246: 'Modest', 1247: 'completers', 1248: 'intention', 1249: '03', 1250: 'primarily', 1251: '78', 1252: 'U', 1253: '00', 1254: '44', 1255: 'Injection', 1256: 'site', 1257: 'reactions', 1258: 'frequent', 1259: 'INTERPRETATION', 1260: 'Supplementation', 1261: 'achieves', 1262: 'important', 1263: 'low', 1264: 'Non', 1265: 'mainly', 1266: 'somewhat', 1267: 'PMC2235909', 1268: '18204830', 1269: '2010', 1270: '967', 1271: '01287', 1272: 'Prandial', 1273: 'regimens', 1274: 'antihyperglycaemic', 1275: 'mealtime', 1276: 'glycaemia', 1277: 'initiate', 1278: 'progressively', 1279: 'advance', 1280: 'Jain', 1281: 'SM', 1282: 'Mao', 1283: 'Escalante', 1284: 'Pulido', 1285: 'Vorokhobina', 1286: 'Lopez', 1287: 'Ilag', 1288: 'LL', 1289: 'TOTALL', 1290: 'Hormone', 1291: 'Indore', 1292: 'India', 1293: 'progressive', 1294: 'approaches', 1295: '≤', 1296: 'lispro', 1297: 'mix', 1298: 'LM50', 1299: 'progression', 1300: 'thrice', 1301: 'premix', 1302: 'PP', 1303: 'beginning', 1304: 'advancing', 1305: 'T2D', 1306: 'showing', 1307: '242', 1308: 'Dinnertime', 1309: 'LM', 1310: 'could', 1311: 'replaced', 1312: '095', 1313: 'Change', 1314: 'A1C', 1315: '76', 1316: '93', 1317: '097', 1318: 'shown', 1319: 'based', 1320: 'prespecified', 1321: 'margin', 1322: '042', 1323: '046', 1324: '405', 1325: 'percentages', 1326: 'rate', 1327: 'Total', 1328: '017', 1329: 'likely', 1330: 'due', 1331: '79', 1332: '011', 1333: 'Both', 1334: 'Higher', 1335: 'Eli', 1336: 'Lilly', 1337: 'Company', 1338: 'PMC2997325', 1339: '20880343', 1340: 'Drug', 1341: 'Investig', 1342: '707', 1343: 's40261', 1344: '013', 1345: '0107', 1346: 'Saxagliptin', 1347: 'Barnett', 1348: 'AH', 1349: 'Charbonnel', 1350: 'Donovan', 1351: 'Fleming', 1352: 'Iqbal', 1353: 'Centre', 1354: 'Heart', 1355: 'England', 1356: 'National', 1357: 'Service', 1358: 'Foundation', 1359: 'Trust', 1360: 'Birmingham', 1361: 'UK', 1362: 'Achievement', 1363: 'objective', 1364: 'management', 1365: 'T2DM', 1366: 'saxagliptin', 1367: 'extension', 1368: 'totaling', 1369: 'dosage', 1370: 'flexible', 1371: 'deemed', 1372: 'appropriate', 1373: 'investigator', 1374: 'practice', 1375: 'setting', 1376: 'family', 1377: 'hospital', 1378: '150', 1379: 'stratified', 1380: 'use', 1381: 'initial', 1382: 'eligible', 1383: 'participate', 1384: 'regardless', 1385: 'required', 1386: 'main', 1387: 'measure', 1388: 'general', 1389: 'Adjusted', 1390: '04', 1391: 'numerically', 1392: 'smaller', 1393: '67', 1394: 'During', 1395: 'reporting', 1396: 'event', 1397: 'AE', 1398: 'majority', 1399: 'being', 1400: 'intensity', 1401: 'common', 1402: 'urinary', 1403: 'tract', 1404: 'infection', 1405: 'nasopharyngitis', 1406: 'upper', 1407: 'respiratory', 1408: 'headache', 1409: 'influenza', 1410: 'pain', 1411: 'extremity', 1412: 'confirmed', 1413: 'fingerstick', 1414: '[≤', 1415: '77', 1416: 'characteristic', 1417: 'concomitant', 1418: 'produced', 1419: 'durable', 1420: 'over', 1421: '23949898', 1422: 'PLoS', 1423: 'e0164255', 1424: '1371', 1425: 'journal', 1426: 'pone', 1427: '0164255', 1428: 'eCollection', 1429: 'Randomized', 1430: 'Comparing', 1431: 'Glimepiride', 1432: 'Endothelial', 1433: 'Function', 1434: 'Parameters', 1435: 'Athero', 1436: 'Incretin', 1437: 'SAIS1', 1438: 'Nomoto', 1439: 'Furumoto', 1440: 'Oba', 1441: 'Tsutsui', 1442: 'Inoue', 1443: 'Manda', 1444: 'Kurihara', 1445: 'Aoki', 1446: 'SAIS', 1447: 'Cardiovascular', 1448: 'NTT', 1449: 'East', 1450: 'Biostatistics', 1451: 'Public', 1452: 'Tokyo', 1453: 'Interfaculty', 1454: 'Initiative', 1455: 'Information', 1456: 'Studies', 1457: 'Community', 1458: 'Healthcare', 1459: 'Organization', 1460: 'Memorial', 1461: 'Clinic', 1462: 'OBJECTIVES', 1463: 'incretin', 1464: 'hyperglycemia', 1465: 'dependent', 1466: 'manner', 1467: 'exert', 1468: 'favorable', 1469: 'atherosclerosis', 1470: 'fully', 1471: 'elucidated', 1472: 'able', 1473: 'endothelial', 1474: 'Therefore', 1475: 'we', 1476: 'sulfonylurea', 1477: 'MATERIALS', 1478: 'outpatients', 1479: 'dietary', 1480: 'cure', 1481: 'current', 1482: 'Flow', 1483: 'mediated', 1484: 'dilation', 1485: 'FMD', 1486: 'comprehensive', 1487: 'panel', 1488: 'hemodynamic', 1489: 'Task', 1490: 'Force', 1491: '®', 1492: 'Monitor', 1493: 'markers', 1494: 'Secretory', 1495: 'islets', 1496: 'transplantation', 1497: 'TNF', 1498: '-α,', 1499: 'adiponectin', 1500: 'biological', 1501: 'antioxidant', 1502: 'superoxide', 1503: 'dismutase', 1504: 'Cardiac', 1505: 'Regardless', 1506: 'early', 1507: 'provide', 1508: 'inflammatory', 1509: 'oxidative', 1510: 'stress', 1511: 'advanced', 1512: 'TRIAL', 1513: 'REGISTRATION', 1514: 'UMIN', 1515: 'Trials', 1516: 'Registry', 1517: 'System', 1518: '000004955', 1519: 'PMC5053511', 1520: '27711199', 1521: 'Conflict', 1522: 'interest', 1523: 'statement', 1524: 'read', 1525: 'authors', 1526: 'manuscript', 1527: 'competing', 1528: 'interests', 1529: 'honoraria', 1530: 'lectures', 1531: 'Astellas', 1532: 'AstraZeneca', 1533: 'Dainippon', 1534: 'Pharma', 1535: 'Kissei', 1536: 'Mitsubishi', 1537: 'Tanabe', 1538: 'MSD', 1539: 'Novartis', 1540: 'Novo', 1541: 'Nordisk', 1542: 'Sanofi', 1543: 'scholarship', 1544: 'grants', 1545: 'Daiichi', 1546: 'Sankyo', 1547: 'Takeda', 1548: 'Taisho', 1549: 'Pharmaceutical', 1550: 'Co', 1551: 'Ltd', 1552: 'Pfizer', 1553: 'Eisai', 1554: 'Avvie', 1555: 'UCB', 1556: 'Chugai', 1557: 'Alexion', 1558: 'Bristol', 1559: 'Myers', 1560: 'Squibb', 1561: 'Janssen', 1562: 'Bayer', 1563: 'does', 1564: 'alter', 1565: 'our', 1566: 'adherence', 1567: 'PLOS', 1568: 'ONE', 1569: 'policies', 1570: 'sharing', 1571: 'materials', 1572: 'Pediatr', 1573: '567', 1574: '1399', 1575: '5448', 1576: '00434', 1577: '27', 1578: 'Short', 1579: 'markedly', 1580: 'adolescents', 1581: 'normal', 1582: 'Burgert', 1583: 'TS', 1584: 'Duran', 1585: 'EJ', 1586: 'Goldberg', 1587: 'Gell', 1588: 'Dziura', 1589: 'Yeckel', 1590: 'CW', 1591: 'Katz', 1592: 'Tamborlane', 1593: 'WV', 1594: 'Caprio', 1595: 'Pediatrics', 1596: 'Yale', 1597: 'New', 1598: 'Haven', 1599: 'CT', 1600: '06520', 1601: 'tania', 1602: 'burgert', 1603: 'yale', 1604: 'edu', 1605: 'Although', 1606: 'MET', 1607: 'sensitizer', 1608: 'currently', 1609: 'adjunct', 1610: 'some', 1611: 'childhood', 1612: 'obesity', 1613: 'besides', 1614: 'few', 1615: 'studies', 1616: 'comprehensively', 1617: 'examined', 1618: 'children', 1619: 'NGT', 1620: 'therefore', 1621: 'month', 1622: 'resistant', 1623: 'whole', 1624: 'sensitivity', 1625: 'WBISI', 1626: 'yr', 1627: '1500', 1628: 'subcutaneous', 1629: 'fat', 1630: 'deep', 1631: 'magnetic', 1632: 'resonance', 1633: 'imaging', 1634: 'Postintervention', 1635: '008', 1636: 'significance', 1637: 'lost', 1638: 'adjustments', 1639: '09', 1640: 'While', 1641: 'cytokines', 1642: 'heart', 1643: 'recovery', 1644: 'worsened', 1645: 'autonomic', 1646: 'trend', 1647: 'toward', 1648: 'ameliorate', 1649: 'consequences', 1650: 'adolescent', 1651: '18761646', 1652: '2489', 1653: '2454', 1654: '29', 1655: 'Adding', 1656: 'lixisenatide', 1657: 'established', 1658: 'GetGoal', 1659: 'Riddle', 1660: 'MC', 1661: 'Aronson', 1662: 'Marre', 1663: 'Niemoeller', 1664: 'Miossec', 1665: 'Ping', 1666: 'Ye', 1667: 'Oregon', 1668: '&', 1669: 'Science', 1670: 'Portland', 1671: 'riddlem', 1672: 'ohsu', 1673: 'examine', 1674: 'glucagon', 1675: 'like', 1676: 'peptide', 1677: 'receptor', 1678: 'agonist', 1679: 'GLP', 1680: '1RA', 1681: 'together', 1682: 'elevated', 1683: '495', 1684: 'μ', 1685: 'unchanged', 1686: 'except', 1687: 'limit', 1688: 'corrected', 1689: '0002', 1690: 'mol', 1691: 'attained', 1692: '0001', 1693: 'Lixisenatide', 1694: 'standardized', 1695: 'breakfast', 1696: 'seven', 1697: 'profiles', 1698: 'persisting', 1699: 'through', 1700: 'Reductions', 1701: '012', 1702: 'Main', 1703: 'Symptomatic', 1704: '328', 1705: 'severe', 1706: '167', 1707: 'By', 1708: 'alternative', 1709: 'rapid', 1710: 'options', 1711: 'PMC3747925', 1712: '23628617', 1713: '2011', 1714: '65', 1715: '01326', 1716: 'Safety', 1717: 'linagliptin', 1718: 'Taskinen', 1719: 'MR', 1720: 'Tamminen', 1721: 'Kubiak', 1722: 'Patel', 1723: 'Dugi', 1724: 'KA', 1725: 'Woerle', 1726: 'HJ', 1727: 'Helsinki', 1728: 'Central', 1729: 'Finland', 1730: 'marja', 1731: 'riitta', 1732: 'taskinen', 1733: 'helsinki', 1734: 'fi', 1735: 'Postgrad', 1736: '123', 1737: '183', 1738: 'potent', 1739: 'carried', 1740: 'out', 1741: '82', 1742: 'centres', 1743: 'countries', 1744: 'maximum', 1745: 'antidiabetes', 1746: 'medication', 1747: '524', 1748: '177', 1749: 'covariance', 1750: 'ANCOVA', 1751: 'Linagliptin', 1752: '58', 1753: '2hPPG', 1754: 'Hypoglycaemia', 1755: 'rare', 1756: 'occurring', 1757: 'resulted', 1758: 'meaningful', 1759: 'Blackwell', 1760: 'Publishing', 1761: '21114605', 1762: '39', 1763: '1972', 1764: '1980', 1765: 'LixiLan', 1766: 'Titratable', 1767: 'Fixed', 1768: 'Ratio', 1769: 'Combination', 1770: 'Glargine', 1771: 'Plus', 1772: 'Inadequately', 1773: 'Aroda', 1774: 'VR', 1775: 'Wysham', 1776: 'Unger', 1777: 'Bellido', 1778: 'Gonz', 1779: 'lez', 1780: 'lvez', 1781: 'Takami', 1782: 'Guo', 1783: 'Souhami', 1784: 'Bergenstal', 1785: 'RM', 1786: 'Medstar', 1787: 'Hyattsville', 1788: 'MD', 1789: 'vanita', 1790: 'aroda', 1791: 'medstar', 1792: 'Rockwood', 1793: 'Spokane', 1794: 'WA', 1795: 'Catalina', 1796: 'Chino', 1797: 'CA', 1798: 'Complejo', 1799: 'Hospitalario', 1800: 'Universitario', 1801: 'Ferrol', 1802: 'Coru', 1803: 'ñ', 1804: 'Instituto', 1805: 'Jalisciense', 1806: 'Investigaci', 1807: 'ó', 1808: 'en', 1809: 'y', 1810: 'Obesidad', 1811: 'Universidad', 1812: 'Guadalajara', 1813: 'Civil', 1814: 'Dr', 1815: 'Juan', 1816: 'Menchaca', 1817: 'Mexico', 1818: 'BMD', 1819: 'Consulting', 1820: 'Somerset', 1821: 'NJ', 1822: 'Frankfurt', 1823: 'Germany', 1824: 'Paris', 1825: 'France', 1826: 'International', 1827: 'Nicollet', 1828: 'Minneapolis', 1829: 'MN', 1830: '2017', 1831: '809', 1832: 'demonstrate', 1833: 'iGlarLixi', 1834: 'novel', 1835: 'titratable', 1836: 'iGlar', 1837: 'introduced', 1838: 'stopped', 1839: '736', 1840: 'm2', 1841: 'final', 1842: 'Documented', 1843: 'comparable', 1844: 'Mild', 1845: 'very', 1846: 'Compared', 1847: 'targets', 1848: 'standing', 1849: 'dc16', 1850: '1495', 1851: '27650977', 1852: 'Lancet', 1853: '382', 1854: '9890', 1855: '409', 1856: '416', 1857: 'S0140', 1858: '6736', 1859: '60995', 1860: 'Individualised', 1861: 'elderly', 1862: 'lone', 1863: 'INTERVAL', 1864: 'Strain', 1865: 'WD', 1866: 'Lukashevich', 1867: 'V', 1868: 'Kothny', 1869: 'Hoellinger', 1870: 'MJ', 1871: 'Pald', 1872: 'nius', 1873: 'PM', 1874: 'Vascular', 1875: 'Exeter', 1876: 'Electronic', 1877: 'address', 1878: 'strain', 1879: 'exeter', 1880: 'uk', 1881: 'Pharmaceuticals', 1882: 'Corporation', 1883: 'Hanover', 1884: 'AG', 1885: 'Basel', 1886: 'Switzerland', 1887: '378', 1888: 'Rev', 1889: '440', 1890: 'Guidelines', 1891: 'suggest', 1892: 'individualised', 1893: 'evidence', 1894: 'aimed', 1895: 'feasibility', 1896: 'along', 1897: 'conventional', 1898: '·', 1899: 'older', 1900: 'Europe', 1901: 'set', 1902: 'basis', 1903: 'comorbidities', 1904: 'frailty', 1905: 'status', 1906: 'validated', 1907: 'automated', 1908: 'per', 1909: 'Coprimary', 1910: 'defined', 1911: 'registered', 1912: 'NCT01257451', 1913: 'European', 1914: 'Union', 1915: 'Regulating', 1916: 'Authorities', 1917: 'database', 1918: '022658', 1919: 'FINDINGS', 1920: 'Between', 1921: 'March', 1922: '137', 1923: 'education', 1924: 'interactions', 1925: 'team', 1926: '72', 1927: 'odds', 1928: '81', 1929: 'finding', 1930: 'accompanied', 1931: 'emergence', 1932: 'signals', 1933: 'introduce', 1934: 'show', 1935: 'achievable', 1936: 'issues', 1937: 'FUNDING', 1938: 'Copyright', 1939: 'Elsevier', 1940: 'rights', 1941: 'reserved', 1942: '23706759', 1943: '1753', 1944: '0407', 1945: '00223', 1946: 'rosiglitazone', 1947: 'Dobs', 1948: 'AS', 1949: 'Goldstein', 1950: 'Aschner', 1951: 'Horton', 1952: 'ES', 1953: 'Umpierrez', 1954: 'GE', 1955: 'Hill', 1956: 'JS', 1957: 'Golm', 1958: 'GT', 1959: 'Langdon', 1960: 'RB', 1961: 'Williams', 1962: 'Herman', 1963: 'DE', 1964: 'Kaufman', 1965: 'KD', 1966: 'Amatruda', 1967: 'Ferreira', 1968: 'JC', 1969: 'Johns', 1970: 'Hopkins', 1971: 'Baltimore', 1972: 'therapeutic', 1973: 'disorder', 1974: 'often', 1975: 'requires', 1976: 'across', 1977: 'North', 1978: 'South', 1979: 'America', 1980: 'Asia', 1981: '278', 1982: 'ranging', 1983: 'Weeks', 1984: 'Significantly', 1985: '003', 1986: '015', 1987: 'Changes', 1988: 'rates', 1989: 'Ruijin', 1990: 'Jiaotong', 1991: 'Wiley', 1992: 'Pty', 1993: '22742523', 1994: 'diabres', 1995: 'folic', 1996: 'acid', 1997: 'biochemical', 1998: 'indices', 1999: 'men', 2000: 'Gargari', 2001: 'BP', 2002: 'Aghamohammadi', 2003: 'Aliasgharzadeh', 2004: 'Nutritional', 2005: 'Biochemistry', 2006: 'Nutrition', 2007: 'Faculty', 2008: 'Tabriz', 2009: 'bahrampg', 2010: 'yahoo', 2011: 'performed', 2012: 'folate', 2013: 'profile', 2014: 'Forty', 2015: 'eight', 2016: 'participated', 2017: 'divided', 2018: 'into', 2019: 'tablets', 2020: 'led', 2021: 'HbA1C', 2022: '048', 2023: '051', 2024: '021', 2025: '041', 2026: 'homocysteine', 2027: '000', 2028: 'B12', 2029: 'Also', 2030: 'Folic', 2031: 'lowered', 2032: 'Ireland', 2033: '21802161', 2034: 'Open', 2035: 'Access', 2036: 'Maced', 2037: 'Sci', 2038: '955', 2039: '962', 2040: '3889', 2041: 'oamjms', 2042: '193', 2043: 'Pioglitazone', 2044: 'Insufficiently', 2045: 'Jameshorani', 2046: 'Sayari', 2047: 'Kiahashemi', 2048: 'Motamed', 2049: 'Zanjan', 2050: 'Disease', 2051: 'ZMDR', 2052: 'Vali', 2053: 'e', 2054: 'asr', 2055: 'ZUMS', 2056: 'Epidemiology', 2057: 'centre', 2058: 'whose', 2059: '83', 2060: '132', 2061: 'sugar', 2062: 'FBS', 2063: '97', 2064: '773', 2065: '08', 2066: 'On', 2067: 'hand', 2068: 'Nevertheless', 2069: 'regarding', 2070: 'PMC5771302', 2071: '29362626', 2072: '154', 2073: '201101180', 2074: '00300', 2075: 'Use', 2076: 'Buse', 2077: 'JB', 2078: 'Glass', 2079: 'LC', 2080: 'Heilmann', 2081: 'CR', 2082: 'Lewis', 2083: 'MS', 2084: 'Kwan', 2085: 'AY', 2086: 'Carolina', 2087: 'Chapel', 2088: '27599', 2089: 'jbuse', 2090: 'unc', 2091: '131', 2092: 'replacement', 2093: 'intervention', 2094: 'reach', 2095: '₁', 2096: 'c', 2097: 'Parallel', 2098: 'blocked', 2099: 'October', 2100: 'January', 2101: 'investigators', 2102: 'personnel', 2103: 'conducting', 2104: 'masked', 2105: 'assignments', 2106: 'NCT00765817', 2107: 'centers', 2108: 'Adults', 2109: 'Assignment', 2110: 'centralized', 2111: 'computer', 2112: 'generated', 2113: 'random', 2114: 'sequence', 2115: 'interactive', 2116: 'voice', 2117: 'response', 2118: 'µ', 2119: 'waist', 2120: 'circumference', 2121: '138', 2122: 'recipients', 2123: '101', 2124: 'Weight', 2125: 'Average', 2126: 'increases', 2127: 'minor', 2128: 'Thirteen', 2129: 'recipient', 2130: '010', 2131: 'diarrhea', 2132: 'constipation', 2133: 'slight', 2134: 'imbalances', 2135: 'terms', 2136: 'sex', 2137: 'medications', 2138: 'withdrew', 2139: 'Adverse', 2140: 'PRIMARY', 2141: 'SOURCE', 2142: 'Alliance', 2143: 'Amylin', 2144: '21138825', 2145: 'Cardiovasc', 2146: 'Diabetol', 2147: '125', 2148: '1186', 2149: 's12933', 2150: '0607', 2151: 'Kitao', 2152: 'Miya', 2153: 'Tsuchida', 2154: 'Edagawa', 2155: 'Oita', 2156: 'Kondo', 2157: 'Takahashi', 2158: 'Sugawara', 2159: 'Kameda', 2160: 'Watanabe', 2161: 'Kito', 2162: 'Endo', 2163: 'Takeuchi', 2164: 'Nagai', 2165: 'Masuda', 2166: 'Kita', 2167: 'Nishi', 2168: 'ku', 2169: '060', 2170: '8638', 2171: 'hmiyoshi', 2172: 'hokudai', 2173: 'jp', 2174: 'Innovation', 2175: 'Dipeptidyl', 2176: 'protective', 2177: 'stage', 2178: 'labeled', 2179: '750', 2180: '', 2181: 'Vilda', 2182: 'Met', 2183: 'Ninety', 2184: 'Eight', 2185: 'dropped', 2186: 'characteristics', 2187: '[-', 2188: 'apolipoprotein', 2189: 'A1', 2190: 'Adiponectin', 2191: 'mL', 2192: 'adipokine', 2193: 'PMC5634845', 2194: '29017497', 2195: 'Curr', 2196: 'Opin', 2197: '513', 2198: '1185', 2199: '03007995', 2200: '665046', 2201: 'poorly', 2202: 'combined', 2203: 'BioMedical', 2204: 'anthony', 2205: 'barnett', 2206: 'heartofengland', 2207: 'nhs', 2208: '455', 2209: 'maintain', 2210: 'rescued', 2211: 'remained', 2212: 'kept', 2213: 'minute', 2214: '3829', 2215: 'min', 2216: '0011', 2217: '120', 2218: '0016', 2219: 'HBA', 2220: 'irrespective', 2221: '3958', 2222: 'Hypoglycemia', 2223: 'NCT00757588', 2224: '22313154', 2225: 'Feb', 2226: '537', 2227: '030079908X260925', 2228: 'Raz', 2229: 'Hussain', 2230: 'Alba', 2231: 'Hadassah', 2232: 'Hebrew', 2233: 'Jerusalem', 2234: 'Israel', 2235: 'purpose', 2236: 'moderately', 2237: '190', 2238: 'OUTCOME', 2239: 'MEASURES', 2240: 'Key', 2241: 'hour', 2242: 'neutral', 2243: 'Addition', 2244: '18194595', 2245: '9902', 2246: '1413', 2247: '61500', 2248: 'Huisman', 2249: 'Jones', 2250: 'von', 2251: 'Eynatten', 2252: 'NHS', 2253: '1386', 2254: '383', 2255: '9914', 2256: '306', 2257: '307', 2258: 'substantial', 2259: 'excluded', 2260: 'effectiveness', 2261: 'combinations', 2262: 'randomisation', 2263: 'concealed', 2264: 'yes', 2265: 'block', 2266: 'size', 2267: 'four', 2268: 'matching', 2269: 'assignment', 2270: 'NCT01084005', 2271: '241', 2272: 'community', 2273: 'living', 2274: '162', 2275: '64', 2276: 'much', 2277: 'same', 2278: 'deaths', 2279: 'Serious', 2280: 'none', 2281: '2083', 2282: 'efficacious', 2283: 'findings', 2284: 'inform', 2285: 'decisions', 2286: 'goals', 2287: 'minimal', 2288: 'Boehringer', 2289: 'Ingelheim', 2290: '23948125', 2291: '726', 2292: 'dmrr', 2293: '2541', 2294: 'Asian', 2295: 'Pan', 2296: 'Han', 2297: 'Tian', 2298: 'Kui', 2299: 'Shang', 2300: 'Chinese', 2301: 'People', 2302: 'Liberation', 2303: 'Army', 2304: 'General', 2305: 'Beijing', 2306: 'absolute', 2307: '391', 2308: '0004', 2309: '0109', 2310: 'loss', 2311: '296', 2312: 'emergent', 2313: 'TEAEs', 2314: 'serious', 2315: 'TEAE', 2316: '1321', 2317: 'insufficiently', 2318: 'Authors', 2319: 'Reviews', 2320: 'published', 2321: 'John', 2322: 'Sons', 2323: '24639432', 2324: 'dc08', 2325: '2117', 2326: 'DURAbility', 2327: 'DURABLE', 2328: 'Wolffenbuttel', 2329: 'BH', 2330: 'WH', 2331: 'Shemonsky', 2332: 'NK', 2333: 'Jiang', 2334: 'HH', 2335: 'Fahrbach', 2336: 'JL', 2337: 'Scism', 2338: 'Bacon', 2339: 'Martin', 2340: 'SA', 2341: 'ability', 2342: 'starter', 2343: 'achieve', 2344: 'large', 2345: 'ethnically', 2346: 'diverse', 2347: 'LM75', 2348: 'protamine', 2349: 'suspension', 2350: '045', 2351: 'GL', 2352: 'continuation', 2353: 'prestudy', 2354: '414', 2355: '005', 2356: 'pt', 2357: '009', 2358: 'Severe', 2359: 'slightly', 2360: 'Durability', 2361: 'will', 2362: 'maintenance', 2363: 'PMC2681037', 2364: '19336625', 2365: '92', 2366: 'composition', 2367: 'factors', 2368: 'Rodr', 2369: 'guez', 2370: 'Moctezuma', 2371: 'JR', 2372: 'Robles', 2373: 'pez', 2374: 'Carmona', 2375: 'Guti', 2376: 'rrez', 2377: 'Rosas', 2378: 'Regional', 2379: 'Mexicano', 2380: 'del', 2381: 'Seguro', 2382: 'Social', 2383: 'rodmoc', 2384: 'prodigy', 2385: 'mx', 2386: 'DM', 2387: 'MATERIAL', 2388: 'Twenty', 2389: 'Before', 2390: 'hip', 2391: 'bioelectric', 2392: 'impedance', 2393: 'triglycerides', 2394: 'cholesterol', 2395: 'homeostatic', 2396: 'quantitative', 2397: 'check', 2398: 'method', 2399: 'Wilcoxon', 2400: 'rank', 2401: 'nine', 2402: 'lean', 2403: '1735', 2404: '413', 2405: '1878', 2406: '505', 2407: 'calories', 2408: 'water', 2409: '84', 2410: 'modifications', 2411: 'lipids', 2412: 'dynamics', 2413: '00385', 2414: '15715892', 2415: '693', 2416: '699', 2417: '1080', 2418: '1277200', 2419: 'Ma', 2420: 'Zheng', 2421: 'Xu', 2422: 'O', 2423: 'Neill', 2424: 'EA', 2425: 'Fujita', 2426: 'KP', 2427: 'Engel', 2428: 'SS', 2429: 'Shankar', 2430: 'RR', 2431: 'b', 2432: 'Nanjing', 2433: 'First', 2434: 'Affiliated', 2435: 'Harbin', 2436: 'Heilongjiang', 2437: 'Second', 2438: 'Tianjin', 2439: 'Merck', 2440: 'Kenilworth', 2441: 'f', 2442: 'Current', 2443: 'Roche', 2444: 'Holding', 2445: '381', 2446: '<\\u2009.', 2447: 'considered', 2448: 'superior', 2449: 'Clinicaltrials', 2450: 'NCT01177384', 2451: '28035868', 2452: '1000', 2453: 'dom', 2454: '12121', 2455: 'Pinget', 2456: 'Goldenberg', 2457: 'Muehlen', 2458: 'Bartmer', 2459: 'HUS', 2460: 'Strasbourg', 2461: 'variable', 2462: '484', 2463: '323', 2464: '161', 2465: '56', 2466: 'small', 2467: '23627775', 2468: '437', 2469: '01209', 2470: 'efficient', 2471: 'protection', 2472: 'individuals', 2473: 'Forst', 2474: 'Larbig', 2475: 'Hohberg', 2476: 'Diessel', 2477: 'Borchert', 2478: 'Roth', 2479: 'Pf', 2480: 'ü', 2481: 'tzner', 2482: 'Development', 2483: 'Mainz', 2484: 'ThomasF', 2485: 'ikfe', 2486: 'Postprandial', 2487: 'release', 2488: 'intact', 2489: 'IP', 2490: 'independent', 2491: 'dysfunction', 2492: 'arm', 2493: 'pilot', 2494: 'GLA', 2495: 'lunch', 2496: 'sampling', 2497: 'BG', 2498: '156', 2499: '119', 2500: 'Fasting', 2501: 'timepoints', 2502: 'induced', 2503: 'reduces', 2504: 'load', 2505: 'effectively', 2506: 'probably', 2507: 'longer', 2508: 'lasting', 2509: 'pharmacodynamic', 2510: 'PMC2871167', 2511: '20415692', 2512: '542', 2513: '989', 2514: 'Comparison', 2515: 'bolus', 2516: 'Raskin', 2517: 'Gylvin', 2518: 'Weng', 2519: 'Chaykin', 2520: 'Southwestern', 2521: '75390', 2522: '8858', 2523: 'Philip', 2524: 'UTSouthwestern', 2525: 'IDet', 2526: 'IGla', 2527: 'aspart', 2528: '385', 2529: 'criterion', 2530: 'met', 2531: 'Det', 2532: 'Gla', 2533: '207', 2534: '0149', 2535: '3995', 2536: 'appeared', 2537: 'cases', 2538: 'better', 2539: 'CONSORT', 2540: 'guideline', 2541: 'LOCF', 2542: 'approach', 2543: 'inconclusive', 2544: 'possible', 2545: 'delta', 2546: '1023', 2547: '5109', 2548: 'Final', 2549: '130', 2550: '135', 2551: '87', 2552: 'safe', 2553: 'Clinically', 2554: '19565569', 2555: '159', 2556: '12189', 2557: 'Dapagliflozin', 2558: 'maintains', 2559: 'reducing', 2560: 'Bolinder', 2561: 'Ljunggren', 2562: 'Ö,', 2563: 'Johansson', 2564: 'Wilding', 2565: 'Langkilde', 2566: 'AM', 2567: 'Sj', 2568: 'ö', 2569: 'str', 2570: 'Sugg', 2571: 'Parikh', 2572: 'Karolinska', 2573: 'Huddinge', 2574: 'Stockholm', 2575: 'Sweden', 2576: 'sodium', 2577: 'cotransporter', 2578: 'SGLT2', 2579: 'hyperglycaemia', 2580: 'excretion', 2581: 'bone', 2582: '102', 2583: 'dapagliflozin', 2584: 'NCT00855166', 2585: '182', 2586: 'followed', 2587: 'blinded', 2588: 'dual', 2589: 'energy', 2590: 'ray', 2591: 'absorptiometry', 2592: 'DXA', 2593: 'turnover', 2594: 'mineral', 2595: 'density', 2596: '140', 2597: 'cm', 2598: 'identified', 2599: 'fracture', 2600: 'UTI', 2601: 'genital', 2602: 'affecting', 2603: '23906445', 2604: 'Diabet', 2605: '634', 2606: 'Continuing', 2607: 'starting', 2608: 'Douek', 2609: 'IF', 2610: 'Allen', 2611: 'Ewings', 2612: 'Gale', 2613: 'Bingley', 2614: 'continuing', 2615: 'need', 2616: 'start', 2617: 'referred', 2618: 'conversion', 2619: 'recruited', 2620: 'started', 2621: 'according', 2622: 'local', 2623: 'measures', 2624: 'satisfaction', 2625: 'positive', 2626: 'score', 2627: 'decreases', 2628: 'lowers', 2629: 'should', 2630: 'transfer', 2631: '1464', 2632: '5491', 2633: '01475', 2634: '15842521', 2635: '2024', 2636: '2037', 2637: 'Prohibited', 2638: 'Medication', 2639: 'Potentially', 2640: 'Overlooked', 2641: 'Confounder', 2642: 'Omarigliptin', 2643: 'Once', 2644: 'weekly', 2645: 'Inhibitor', 2646: 'Monotherapy', 2647: 'olds', 2648: 'Gantz', 2649: 'Sokolova', 2650: 'Iredale', 2651: 'Wei', 2652: 'Lam', 2653: 'Suryawanshi', 2654: 'Jersey', 2655: 'ira', 2656: 'gantz', 2657: 'merck', 2658: 'Komisarenko', 2659: 'Academy', 2660: 'Ukraine', 2661: 'Kiev', 2662: 'PURPOSE', 2663: 'omarigliptin', 2664: 'young', 2665: 'adult', 2666: 'Unexpected', 2667: 'series', 2668: 'investigations', 2669: 'prohibited', 2670: 'agent', 2671: 'objectives', 2672: 'postmeal', 2673: 'Additional', 2674: 'conduct', 2675: 'measurement', 2676: 'samples', 2677: 'collected', 2678: 'future', 2679: 'biomedical', 2680: 'available', 2681: 'half', 2682: 'male', 2683: '535', 2684: 'allocation', 2685: 'dispensing', 2686: 'supply', 2687: 'compliance', 2688: 'sample', 2689: 'handling', 2690: 'Measurement', 2691: 'uncovered', 2692: 'knowledge', 2693: 'protocol', 2694: 'ie', 2695: 'IMPLICATIONS', 2696: 'confounding', 2697: 'factor', 2698: 'invalidated', 2699: 'behavior', 2700: 'encouraged', 2701: 'underappreciated', 2702: 'confounder', 2703: 'REGISTRATIONS', 2704: 'MK', 2705: '3102', 2706: '028', 2707: 'US', 2708: 'identifier', 2709: 'NCT01814748', 2710: 'EudraCT', 2711: '004303', 2712: 'EU', 2713: 'Published', 2714: '28923291', 2715: '1853', 2716: '1860', 2717: '1335637', 2718: 'evaluating', 2719: 'Inzucchi', 2720: 'Scarabello', 2721: 'Ceesay', 2722: 'Section', 2723: 'q', 2724: 'w', 2725: '201', 2726: 'timepoint', 2727: '=\\u2009.', 2728: 'incidences', 2729: 'discontinuations', 2730: '104', 2731: 'welltolerated', 2732: '28547998', 2733: '196', 2734: 'dme', 2735: '13256', 2736: 'degludec', 2737: 'liraglutide', 2738: 'IDegLira', 2739: 'sulphonylurea', 2740: 'DUAL', 2741: 'IV', 2742: 'Rodbard', 2743: 'HW', 2744: 'Bode', 2745: 'BW', 2746: 'Harris', 2747: 'SB', 2748: 'Rose', 2749: 'Lehmann', 2750: 'Jarlov', 2751: 'Thurman', 2752: 'Dual', 2753: 'Action', 2754: 'Liraglutide', 2755: 'Consultants', 2756: 'Rockville', 2757: 'Atlanta', 2758: 'Associates', 2759: 'GA', 2760: 'Family', 2761: 'London', 2762: 'ON', 2763: 'nster', 2764: 'ø', 2765: 'borg', 2766: 'SSM', 2767: 'St', 2768: 'Louis', 2769: 'MO', 2770: 'investigate', 2771: 'product', 2772: '289', 2773: 'titrating', 2774: 'steps', 2775: 'Confirmed', 2776: 'exposure', 2777: 'obvious', 2778: 'patterns', 2779: 'can', 2780: 'line', 2781: 'previous', 2782: 'trials', 2783: 'PMC5811787', 2784: '27589252', 2785: '73', 2786: 'Nine', 2787: 'diazoxide', 2788: 'Qvigstad', 2789: 'Kollind', 2790: 'Grill', 2791: 'Olav', 2792: 'Trondheim', 2793: 'Norway', 2794: 'elisabeth', 2795: 'qvigstad', 2796: 'stolav', 2797: '243', 2798: 'side', 2799: 'female', 2800: 'Duplicate', 2801: 'tests', 2802: 'last', 2803: 'days', 2804: 'detected', 2805: 'incur', 2806: 'responses', 2807: 'nmol', 2808: 'Corresponding', 2809: 'pmol', 2810: 'Glycated', 2811: 'affected', 2812: '43', 2813: 'Bedtime', 2814: 'tends', 2815: 'fails', 2816: '14706058', 2817: '01173', 2818: 'Vilsb', 2819: 'll', 2820: 'Yki', 2821: 'ä', 2822: 'rvinen', 2823: 'Cefalu', 2824: 'WT', 2825: 'Musser', 2826: 'Ling', 2827: 'Gentofte', 2828: 'Copenhagen', 2829: 'intermediate', 2830: 'premixed', 2831: 'capped', 2832: 'Further', 2833: 'remain', 2834: '322', 2835: '319', 2836: 'Similar', 2837: 'strata', 2838: 'insulins', 2839: 'hypoglycaemic', 2840: 'criteria', 2841: 'severity', 2842: '20092585', 2843: '501', 2844: 'Eliaschewitz', 2845: 'FG', 2846: 'Calvo', 2847: 'Valbuena', 2848: 'Ruiz', 2849: 'Villena', 2850: 'Ramirez', 2851: 'LA', 2852: 'Jimenez', 2853: '4013', 2854: 'Heli', 2855: 'polis', 2856: 'ã', 2857: 'o', 2858: 'Paulo', 2859: 'Brazil', 2860: 'freddy', 2861: 'uol', 2862: 'br', 2863: 'fail', 2864: 'adequate', 2865: 'OADs', 2866: 'ten', 2867: 'Latin', 2868: '231', 2869: '250', 2870: 'forced', 2871: 'algorithm', 2872: 'equivalence', 2873: '047', 2874: '232', 2875: '014', 2876: 'full', 2877: 'work', 2878: 'activities', 2879: '16715577', 2880: '252', 2881: '12020', 2882: 'Improved', 2883: 'Foley', 2884: 'Kozlovski', 2885: 'Shao', 2886: 'Gallwitz', 2887: '07936', 2888: 'wolfgang', 2889: 'kothny', 2890: 'novartis', 2891: 'bid', 2892: '449', 2893: '228', 2894: '221', 2895: 'Vildagliptin', 2896: 'similarly', 2897: 'spite', 2898: '23039321', 2899: '1389', 2900: '1396', 2901: '12955', 2902: 'fast', 2903: 'onset', 2904: 'Tripathy', 2905: 'Vidrio', 2906: 'Vel', 2907: 'zquez', 2908: 'Demissie', 2909: 'Tamer', 2910: 'SC', 2911: 'Pileti', 2912: 'č', 2913: 'Maryland', 2914: 'San', 2915: 'Audie', 2916: 'Murphy', 2917: 'VA', 2918: '110', 2919: 'Mesto', 2920: 'Slovenia', 2921: 'confirm', 2922: 'superiority', 2923: 'faster', 2924: 'BB', 2925: '236', 2926: ']\\u2009±', 2927: '%\\u2009±', 2928: 'optimization', 2929: 'prior', 2930: '116', 2931: 'Primary', 2932: 'increment', 2933: 'meals', 2934: 'favour', 2935: 'Obesity', 2936: 'PMC5637905', 2937: '28345792', 2938: '2349', 2939: 'Mealtime', 2940: 'analogue', 2941: 'mixture', 2942: 'achievement', 2943: 'Robbins', 2944: 'DC', 2945: 'Beisswenger', 2946: 'Ceriello', 2947: 'Moses', 2948: 'Pagkalos', 2949: 'EM', 2950: 'Milicevic', 2951: 'Sarwat', 2952: 'Tan', 2953: 'MH', 2954: 'Platform', 2955: 'Team', 2956: 'Indianapolis', 2957: 'IN', 2958: '46285', 2959: 'secretion', 2960: 'remainder', 2961: 'Hence', 2962: 'would', 2963: 'expected', 2964: 'mimic', 2965: 'physiologic', 2966: 'Using', 2967: 'logical', 2968: 'lc', 2969: 'hypothesis', 2970: 'containing', 2971: 'Australia', 2972: 'Greece', 2973: 'Poland', 2974: 'Puerto', 2975: 'Rico', 2976: 'Male', 2977: 'ILPS', 2978: 'TID', 2979: 'maximally', 2980: 'BID', 2981: 'QD', 2982: 'FBG', 2983: 'PPBG', 2984: '144', 2985: 'switched', 2986: 'presupper', 2987: '315', 2988: 'women', 2989: '157', 2990: 'reached', 2991: 'preprandial', 2992: 'prelunch', 2993: 'postbreakfast', 2994: 'postlunch', 2995: 'postsupper', 2996: 'expression', 2997: 'glycemia', 2998: 'swings', 2999: 'Excerpta', 3000: 'Medica', 3001: '016', 3002: '18158076', 3003: '3080', 3004: 'Gerich', 3005: '4002', 3006: '97201', 3007: 'abilities', 3008: 'risks', 3009: '756', 3010: 'simple', 3011: 'seeking', 3012: 'Outcome', 3013: 'documented', 3014: '117', 3015: 'nearly', 3016: 'categories', 3017: 'Systematically', 3018: 'safely', 3019: 'doing', 3020: 'causes', 3021: 'thus', 3022: 'leading', 3023: 'barrier', 3024: 'initiating', 3025: 'facilitate', 3026: 'earlier', 3027: 'routine', 3028: 'medical', 3029: 'recommended', 3030: 'standards', 3031: 'care', 3032: '14578243', 3033: 'Malaysia', 3034: 'Cabergoline', 3035: 'failure', 3036: 'Taghavi', 3037: 'Fatemi', 3038: 'Rokni', 3039: 'Mashhad', 3040: 'Ahmad', 3041: 'Abad', 3042: 'Khorasan', 3043: '9187883655', 3044: 'Islamic', 3045: 'Republic', 3046: 'taghavimr', 3047: 'mums', 3048: 'Ergot', 3049: 'derived', 3050: 'dopamine', 3051: 'D2', 3052: 'agonists', 3053: 'usual', 3054: 'hyperprolactinemia', 3055: 'Parkinson', 3056: 'recently', 3057: 'approved', 3058: 'evaluation', 3059: 'cabergoline', 3060: 'refused', 3061: 'persistent', 3062: 'II', 3063: '210', 3064: 'insignificantly', 3065: '264', 3066: '203', 3067: '23082447', 3068: '951', 3069: '957', 3070: '1770', 3071: 'Faster', 3072: 'Aspart', 3073: 'Versus', 3074: 'Part', 3075: 'Bolus', 3076: 'Regimen', 3077: 'Bowering', 3078: 'Case', 3079: 'Harvey', 3080: 'Reeves', 3081: 'Sampson', 3082: 'Strzinek', 3083: 'Bretler', 3084: 'Bang', 3085: 'Alberta', 3086: 'Edmonton', 3087: 'keith', 3088: 'bowering', 3089: 'ualberta', 3090: 'Jefferson', 3091: 'Gladstone', 3092: 'Maelor', 3093: 'Bangor', 3094: 'Wrexham', 3095: 'Chattanooga', 3096: 'TN', 3097: 'Norfolk', 3098: 'Norwich', 3099: 'Hospitals', 3100: 'Protenium', 3101: 'Hurst', 3102: '2018', 3103: 'e27', 3104: 'e28', 3105: 'e29', 3106: 'e30', 3107: 'IAsp', 3108: 'optimize', 3109: '345', 3110: '344', 3111: 'driven', 3112: 'U100', 3113: 'noninferiority', 3114: 'ETD', 3115: 'liquid', 3116: 'favor', 3117: '0198', 3118: 'Postmeal', 3119: 'noninferior', 3120: '28483786', 3121: '1149', 3122: '01484', 3123: 'Koivisto', 3124: 'Cleall', 3125: 'Pontiroli', 3126: 'Giugliano', 3127: 'Deutschland', 3128: 'GmbH', 3129: 'Bad', 3130: 'Homburg', 3131: 'koivisto_veikko', 3132: 'lilly', 3133: 'Three', 3134: 'eighty', 3135: 'predefined', 3136: 'country', 3137: 'vital', 3138: 'signs', 3139: 'square', 3140: 'variables', 3141: 'inferior', 3142: '21819517', 3143: '1252', 3144: '1259', 3145: '12945', 3146: 'Reduction', 3147: 'Japanese', 3148: 'NEXTAGE', 3149: 'Yamada', 3150: 'Senda', 3151: 'Naito', 3152: 'Tamura', 3153: 'Shuto', 3154: 'Urita', 3155: 'Geriatric', 3156: 'Akita', 3157: 'Affairs', 3158: 'Operations', 3159: 'Programming', 3160: 'Emergency', 3161: 'Toho', 3162: 'Omori', 3163: 'pharmacodynamics', 3164: 'NCT02200991', 3165: '136', 3166: 'via', 3167: 'injection', 3168: 'initially', 3169: 'hours', 3170: 'AUC0', 3171: '00h', 3172: 'extent', 3173: '347', 3174: '113', 3175: '234', 3176: '285', 3177: 'excursion', 3178: '122', 3179: 'glycoalbumin', 3180: 'gastric', 3181: 'emptying', 3182: 'PMC5573929', 3183: '28345162', 3184: 'e263', 3185: '03722', 3186: 'anti', 3187: 'hyperglycaemic', 3188: 'PARADIGM', 3189: 'Reed', 3190: 'Felicio', 3191: 'Landry', 3192: 'Ji', 3193: 'Oliveira', 3194: 'AB', 3195: '1473', 3196: 'intensification', 3197: 'LM25', 3198: 'multi', 3199: '426', 3200: 'progressing', 3201: '211', 3202: '184', 3203: 'found', 3204: 'minus', 3205: 'course', 3206: 'intensifying', 3207: 'Diabetic', 3208: '22672081', 3209: 'Technol', 3210: '1089', 3211: 'dia', 3212: '0167', 3213: 'Mudaliar', 3214: 'Henry', 3215: 'Boden', 3216: 'Smith', 3217: 'Chalamandaris', 3218: 'Duchesne', 3219: 'List', 3220: 'Diego', 3221: 'California', 3222: 'inhibition', 3223: 'secretagogue', 3224: 'SUBJECTS', 3225: 'measuring', 3226: 'disappearance', 3227: 'GDR', 3228: 'hyperinsulinemic', 3229: 'euglycemic', 3230: 'clamp', 3231: 'acute', 3232: 'AIRg', 3233: 'frequently', 3234: 'sampled', 3235: 'intravenous', 3236: 'Where', 3237: 'observation', 3238: 'forward', 3239: '99', 3240: '0059', 3241: 'mU', 3242: '0598', 3243: 'numerical', 3244: '24237386', 3245: '515', 3246: 'benfluorex', 3247: 'Moulin', 3248: 'Andre', 3249: 'Alawi', 3250: 'dos', 3251: 'Santos', 3252: 'Khalid', 3253: 'AK', 3254: 'Koev', 3255: 'Moore', 3256: 'Serban', 3257: 'Picandet', 3258: 'Francillard', 3259: 'Claude', 3260: 'Bernard', 3261: 'Lyon', 3262: 'philippe', 3263: 'moulin', 3264: 'chu', 3265: 'lyon', 3266: 'fr', 3267: 'whom', 3268: 'limitation', 3269: 'contraindication', 3270: 'poor', 3271: '450', 3272: '165', 3273: '160', 3274: 'covariates', 3275: 'resulting', 3276: 'causality', 3277: 'relationship', 3278: 'Benfluorex', 3279: 'dc05', 3280: '1439', 3281: '16505498', 3282: '1176', 3283: 'dc09', 3284: '2294', 3285: 'Swinnen', 3286: 'SG', 3287: 'Dain', 3288: 'MP', 3289: 'Gerstein', 3290: 'HC', 3291: 'Pfeiffer', 3292: 'AF', 3293: 'Snoek', 3294: 'FJ', 3295: 'Devries', 3296: 'JH', 3297: 'Hoekstra', 3298: 'Holleman', 3299: 'Academic', 3300: 'Amsterdam', 3301: 'swinnen', 3302: 'amc', 3303: 'uva', 3304: '973', 3305: 'systematically', 3306: 'demonstrating', 3307: 'Improvements', 3308: '149', 3309: '254', 3310: 'PMC2875419', 3311: '20200301', 3312: '635', 3313: '643', 3314: '12866', 3315: 'gemigliptin', 3316: 'TROICA', 3317: 'Ahn', 3318: 'CH', 3319: 'Nam', 3320: 'JY', 3321: 'KJ', 3322: 'Oh', 3323: 'TK', 3324: 'Lee', 3325: 'DH', 3326: 'Chung', 3327: 'SW', 3328: 'HK', 3329: 'Ko', 3330: 'Jang', 3331: 'KS', 3332: 'Seoul', 3333: 'Korea', 3334: 'Eulji', 3335: 'Hallym', 3336: 'Kangnam', 3337: 'Sacred', 3338: 'Insurance', 3339: 'Ilsan', 3340: 'Goyang', 3341: 'Kyung', 3342: 'Hee', 3343: 'Gangdong', 3344: 'Chungbuk', 3345: 'Cheongju', 3346: 'Yeungnam', 3347: 'Daegu', 3348: 'Wonkwang', 3349: 'Iksan', 3350: 'Ang', 3351: 'Yonsei', 3352: 'Wonju', 3353: 'Severance', 3354: 'Christian', 3355: 'Chonbuk', 3356: 'Jeonju', 3357: 'Gachon', 3358: 'Gil', 3359: 'Incheon', 3360: 'CHA', 3361: 'Bundang', 3362: 'Seongnam', 3363: 'Soonchunhyang', 3364: 'Daedong', 3365: 'Busan', 3366: 'Kangwon', 3367: 'Chuncheon', 3368: 'Inje', 3369: 'Paik', 3370: 'Jeju', 3371: 'Sejong', 3372: 'Bucheon', 3373: 'LG', 3374: 'Life', 3375: 'College', 3376: 'Biopharmaceutical', 3377: 'Convergence', 3378: 'Technology', 3379: '219', 3380: 'Korean', 3381: 'LDL', 3382: 'Gemigliptin', 3383: 'highlights', 3384: 'importance', 3385: 'optimal', 3386: 'adjustment', 3387: '28026912', 3388: '1976', 3389: 'Hollander', 3390: 'Cooper', 3391: 'Bregnh', 3392: 'Pedersen', 3393: 'CB', 3394: 'Baylor', 3395: '75246', 3396: 'PriscilH', 3397: 'baylorhealth', 3398: '1124', 3399: 'author', 3400: 'reply', 3401: '1125', 3402: 'component', 3403: 'openlabel', 3404: 'diagnosis', 3405: 'OAD', 3406: 'According', 3407: 'labeling', 3408: 'mealtimes', 3409: 'secretagogues', 3410: 'glucosidase', 3411: 'entry', 3412: 'existing', 3413: 'prebreakfast', 3414: 'predinner', 3415: 'scheduled', 3416: 'visits', 3417: 'SMPG', 3418: 'white', 3419: 'shape', 3420: 'Major', 3421: '185', 3422: '214', 3423: '743', 3424: '105', 3425: '377', 3426: 'part', 3427: '19108786', 3428: '432', 3429: '2382', 3430: 'bile', 3431: 'sequestrants', 3432: 'hepatic', 3433: 'novo', 3434: 'lipogenesis', 3435: 'kinetics', 3436: 'Beysen', 3437: 'Deines', 3438: 'Chan', 3439: 'Tsang', 3440: 'Turner', 3441: 'Protasio', 3442: 'Riiff', 3443: 'Hellerstein', 3444: 'Kinemed', 3445: '5980', 3446: 'Street', 3447: 'Suite', 3448: '470', 3449: 'Emeryville', 3450: '94608', 3451: 'cbeysen', 3452: 'kinemed', 3453: '128', 3454: 'elucidate', 3455: 'mechanisms', 3456: 'colesevelam', 3457: 'secondarily', 3458: 'synthesis', 3459: 'triacylglycerols', 3460: 'thereof', 3461: 'central', 3462: 'coordinator', 3463: 'pathways', 3464: 'isotope', 3465: 'techniques', 3466: 'Plasma', 3467: 'insulinotropic', 3468: 'polypeptide', 3469: 'GIP', 3470: 'fibroblast', 3471: 'growth', 3472: 'FGF', 3473: 'state', 3474: 'Data', 3475: 'clearance', 3476: 'glycolytic', 3477: 'disposal', 3478: 'Colesevelam', 3479: 'gluconeogenesis', 3480: 'appearance', 3481: 'absorption', 3482: 'endogenous', 3483: 'production', 3484: 'glycogenolysis', 3485: 'statistical', 3486: 'HOMA', 3487: 'fractional', 3488: 'absorbed', 3489: 'sequestrant', 3490: 'circulating', 3491: 'incretins', 3492: 'tissue', 3493: 'states', 3494: 'NCT00596427', 3495: 'funded', 3496: '22134839', 3497: 'Complications', 3498: '386', 3499: 'jdiacomp', 3500: 'Beneficial', 3501: 'excess', 3502: 'Hanefeld', 3503: 'Shamanna', 3504: 'Min', 3505: 'KW', 3506: 'Boka', 3507: 'Ratner', 3508: 'RE', 3509: 'JulioRosenstock', 3510: 'DallasDiabetes', 3511: 'GWT', 3512: 'TUD', 3513: 'Dresden', 3514: 'Bangalore', 3515: 'Chilly', 3516: 'Mazarin', 3517: 'Bridgewater', 3518: 'Georgetown', 3519: 'Washington', 3520: 'SU', 3521: 'stepwise', 3522: 'top', 3523: 'SUs', 3524: '111', 3525: 'SAEs', 3526: '24650952', 3527: 'Srp', 3528: 'Arh', 3529: 'Celok', 3530: 'Lek', 3531: '447', 3532: 'Article', 3533: 'Serbian', 3534: 'Vukovi', 3535: 'ć', 3536: 'Lapcevi', 3537: 'Kalezi', 3538: 'Gvozdenovi', 3539: 'BS', 3540: 'INTRODUCTION', 3541: 'appear', 3542: 'peripheral', 3543: 'tissues', 3544: 'output', 3545: 'establish', 3546: 'METHOD', 3547: 'comparative', 3548: 'multicentric', 3549: 'department', 3550: 'OPD', 3551: 'Tefor', 3552: 'ICN', 3553: 'newly', 3554: 'diagnosed', 3555: 'Mass', 3556: 'biochemistry', 3557: 'done', 3558: 'insulinaemia', 3559: 'HDL', 3560: 'gamma', 3561: 'glutaryl', 3562: 'transferase', 3563: 'GGT', 3564: 'again', 3565: 'Analysis', 3566: 'identification', 3567: 'co', 3568: 'variants', 3569: 'ANOVA', 3570: 'way', 3571: 'six', 3572: '392', 3573: '667', 3574: 'interacting', 3575: 'interaction', 3576: 'covariants', 3577: 'As', 3578: '807', 3579: '114', 3580: 'concluded', 3581: 'place', 3582: 'bo', 3583: 'productive', 3584: 'indicating', 3585: 'protects', 3586: 'pancreas', 3587: 'depletion', 3588: '17929538', 3589: '916', 3590: '01257', 3591: 'Strojek', 3592: 'Carey', 3593: 'MA', 3594: 'Jacober', 3595: 'SJ', 3596: 'Diseases', 3597: 'Diabetology', 3598: 'Silesian', 3599: 'Zabrze', 3600: 'help', 3601: 'compares', 3602: 'OAM', 3603: '471', 3604: 'OAMs', 3605: 'injected', 3606: 'Least', 3607: 'margins', 3608: 'Percentages', 3609: '20920045', 3610: '443', 3611: '12234', 3612: 'Kalra', 3613: 'Brook', 3614: 'Sockler', 3615: 'Monyak', 3616: 'Visvanathan', 3617: 'Montanaro', 3618: 'Fisher', 3619: 'Wollongong', 3620: 'Illawarra', 3621: 'Shoalhaven', 3622: 'Local', 3623: 'District', 3624: 'consisting', 3625: 'assessments', 3626: '257', 3627: '129', 3628: '255', 3629: '127', 3630: '0272', 3631: '24205943', 3632: '2408', 3633: '2415', 3634: '13394', 3635: 'ipragliflozin', 3636: 'Chon', 3637: 'Lim', 3638: 'Baik', 3639: 'Jung', 3640: 'DS', 3641: 'Yoon', 3642: 'KH', 3643: 'IK', 3644: 'Cha', 3645: 'Sakatani', 3646: 'Nowon', 3647: 'Gangwon', 3648: 'Ajou', 3649: 'Suwon', 3650: 'si', 3651: 'Guro', 3652: 'Asan', 3653: 'Ulsan', 3654: 'Hanyang', 3655: 'Mary', 3656: 'Catholic', 3657: 'Kyungpook', 3658: 'Samsung', 3659: 'Sungkyunkwan', 3660: 'III', 3661: 'EOT', 3662: '143', 3663: 'analyses', 3664: 'corresponding', 3665: 'More', 3666: 'unreported', 3667: 'concerns', 3668: 'Ipragliflozin', 3669: 'good', 3670: 'PMC6175352', 3671: '29862619', 3672: '1861', 3673: '1868', 3674: '1335638', 3675: 'Handelsman', 3676: 'Lauring', 3677: 'Tarzana', 3678: '2095', 3679: '2093', 3680: '2094', 3681: '376', 3682: '375', 3683: 'declaring', 3684: 'exception', 3685: 'Relative', 3686: '28548024', 3687: '1131', 3688: '1162773', 3689: 'fluctuations', 3690: 'Xiaoyan', 3691: 'Jing', 3692: 'Xiaochun', 3693: 'Yuyu', 3694: 'Shunyou', 3695: 'Yingyu', 3696: 'Guangzhou', 3697: 'Objective', 3698: 'design', 3699: 'methods', 3700: 'active', 3701: 'gliclazide', 3702: 'Results', 3703: '091', 3704: 'limitations', 3705: 'Conclusion', 3706: 'ChiCTR', 3707: 'TRC', 3708: '13003858', 3709: '26950829', 3710: 'Exp', 3711: 'Starting', 3712: 'biphasic', 3713: 'Kann', 3714: 'PH', 3715: 'Wascher', 3716: 'Zackova', 3717: 'Moeller', 3718: 'Medding', 3719: 'Szocs', 3720: 'Mokan', 3721: 'Mrevlje', 3722: 'Regulski', 3723: 'Philipps', 3724: 'Universit', 3725: 't', 3726: 'Marburg', 3727: 'Zentrum', 3728: 'r', 3729: 'Innere', 3730: 'Medizin', 3731: 'Bereich', 3732: 'Endokrinologie', 3733: 'Diabetologie', 3734: 'kannp', 3735: 'uni', 3736: 'marburg', 3737: 'soluble', 3738: 'protaminated', 3739: 'BIAsp', 3740: 'glarg', 3741: 'glim', 3742: '0747', 3743: '0124', 3744: 'Glarg', 3745: '0762', 3746: '949655', 3747: '17115351', 3748: '565', 3749: '0453', 3750: 'imeglimin', 3751: 'Fouqueray', 3752: 'Pirags', 3753: 'Bailey', 3754: 'CJ', 3755: 'Diamant', 3756: 'Lebovitz', 3757: 'HE', 3758: 'Poxel', 3759: 'pascale', 3760: 'fouqueray', 3761: 'poxelpharma', 3762: 'subtracted', 3763: 'offers', 3764: 'PMC3579350', 3765: '23160726', 3766: 'Silver', 3767: 'Spring', 3768: '238', 3769: 'oby', 3770: '20042', 3771: 'taspoglutide', 3772: 'emerge', 3773: 'Lasko', 3774: 'Bengus', 3775: 'Kanitra', 3776: 'Pi', 3777: 'Sunyer', 3778: 'FX', 3779: 'Balena', 3780: 'priscilh', 3781: 'BaylorHealth', 3782: 'Therapies', 3783: 'benefits', 3784: 'LSMean', 3785: 'Decreases', 3786: 'Nausea', 3787: 'transient', 3788: 'Society', 3789: '23404788', 3790: '12284', 3791: 'Izumoto', 3792: 'Tongren', 3793: 'Capital', 3794: 'Chongqing', 3795: 'Bracknell', 3796: 'Trading', 3797: 'Nippon', 3798: 'Despite', 3799: 'prevalence', 3800: 'dominated', 3801: 'Caucasian', 3802: 'Western', 3803: 'populations', 3804: 'Phase', 3805: '265', 3806: 'Malaysian', 3807: 'Filipino', 3808: 'Antidiabetes', 3809: 'washed', 3810: 'matched', 3811: '[±', 3812: '25753488', 3813: '115', 3814: '01165', 3815: 'GINGER', 3816: 'Fritsche', 3817: 'Owens', 3818: 'ring', 3819: 'HU', 3820: 'Medizinische', 3821: 'tsklinik', 3822: 'Abteilung', 3823: 'Stoffwechsel', 3824: 'und', 3825: 'Pathobiochemie', 3826: 'Eberhard', 3827: 'Karls', 3828: '72076', 3829: 'bingen', 3830: '1022', 3831: '926', 3832: 'intensified', 3833: 'glulisine', 3834: '310', 3835: '476', 3836: 'Cl', 3837: '714', 3838: 'ancova', 3839: '0033', 3840: 'Endpoint', 3841: '2104', 3842: '0073', 3843: '2385', 3844: '20092584', 3845: '1087', 3846: '12322', 3847: 'transporter', 3848: 'canagliflozin', 3849: 'volume', 3850: 'Sha', 3851: 'Polidori', 3852: 'Heise', 3853: 'Natarajan', 3854: 'Farrell', 3855: 'Sica', 3856: 'Rothenberg', 3857: 'Plum', 3858: 'rschel', 3859: 'LLC', 3860: 'Raritan', 3861: 'UGE', 3862: 'fluid', 3863: 'electrolyte', 3864: 'balance', 3865: 'angiotensin', 3866: 'converting', 3867: 'enzyme', 3868: 'blockers', 3869: '300', 3870: 'Pharmacodynamic', 3871: 'Increased', 3872: 'Canagliflozin', 3873: 'attenuated', 3874: 'urine', 3875: 'i', 3876: 'urea', 3877: 'nitrogen', 3878: 'creatinine', 3879: 'haematocrit', 3880: '24939043', 3881: '2638', 3882: 'Karasik', 3883: 'Meininger', 3884: '020', 3885: 'Hospitalier', 3886: 'Universitaire', 3887: 'Nantes', 3888: '701', 3889: 'specific', 3890: 'limits', 3891: 'obtained', 3892: 'AUCs', 3893: 'dc06', 3894: '0706', 3895: '17130197', 3896: '1505', 3897: '12495', 3898: 'Bajaj', 3899: 'Gilman', 3900: 'Kempthorne', 3901: 'Rawson', 3902: 'Agostino', 3903: 'Houston', 3904: 'se', 3905: '0280', 3906: 'Investigator', 3907: 'NCT', 3908: '00996658', 3909: 'behalf', 3910: 'PMC4257097', 3911: '24824197', 3912: '3121', 3913: 'dc14', 3914: '1038', 3915: 'methazolamide', 3916: 'Simpson', 3917: 'RW', 3918: 'Nicholson', 3919: 'GC', 3920: 'Proietto', 3921: 'Sarah', 3922: 'Sanders', 3923: 'KM', 3924: 'Phillips', 3925: 'Chambers', 3926: 'MacGinley', 3927: 'Orford', 3928: 'Walder', 3929: 'Krippner', 3930: 'Skoff', 3931: 'Wacher', 3932: 'VJ', 3933: 'Box', 3934: 'Victoria', 3935: 'Biomedical', 3936: 'Geelong', 3937: 'Melbourne', 3938: 'Heidelberg', 3939: 'Repatriation', 3940: 'Barwon', 3941: 'Deakin', 3942: 'Preventive', 3943: 'Australian', 3944: 'Zealand', 3945: 'Intensive', 3946: 'Monash', 3947: 'Verva', 3948: 'Southbank', 3949: 'vwacher', 3950: 'vervapharma', 3951: 'Δ', 3952: 'Methazolamide', 3953: 'alanine', 3954: 'aminotransferase', 3955: '∼', 3956: 'cotreated', 3957: 'archetype', 3958: 'beyond', 3959: 'Readers', 3960: 'article', 3961: 'properly', 3962: 'cited', 3963: 'educational', 3964: 'profit', 3965: 'altered', 3966: '25125506', 3967: '348', 3968: '1358759', 3969: 'Rigby', 3970: 'SP', 3971: 'Ford', 3972: 'Tao', 3973: 'Chou', 3974: 'HS', 3975: 'Summit', 3976: 'Stow', 3977: 'Ohio', 3978: 'Edison', 3979: 'lipoprotein', 3980: '176', 3981: '181', 3982: '0005', 3983: 'unexpected', 3984: 'close', 3985: 'quite', 3986: 'NCT00789737', 3987: 'Georg', 3988: 'Thieme', 3989: 'Verlag', 3990: 'KG', 3991: 'Stuttgart', 3992: 'York', 3993: '24356792', 3994: '826', 3995: 'processing', 3996: 'contributes', 3997: 'enhancement', 3998: 'Ahr', 3999: 'Pacini', 4000: 'Tura', 4001: 'JE', 4002: 'Schweizer', 4003: 'Lund', 4004: 'Bo', 4005: 'Ahren', 4006: 'lu', 4007: 'contribution', 4008: 'fastP', 4009: '052', 4010: 'Following', 4011: 'dynamic', 4012: 'dynP', 4013: '037', 4014: 'Importantly', 4015: 'expressed', 4016: 'relation', 4017: 'stimulus', 4018: '240', 4019: '023', 4020: 'postprandially', 4021: '004', 4022: 'conclusion', 4023: 'provides', 4024: 'ameliorates', 4025: 'abnormal', 4026: '991172', 4027: '17992639', 4028: '227', 4029: '00213', 4030: 'Shentu', 4031: 'Johnson', 4032: 'Levonas', 4033: 'AO', 4034: 'Friendship', 4035: 'failed', 4036: '395', 4037: '1700', 4038: '5kg', 4039: '018', 4040: '22672586', 4041: '2475', 4042: '3360', 4043: 'HARMONY', 4044: 'albiglutide', 4045: 'Weissman', 4046: 'PN', 4047: 'Carr', 4048: 'Cirkel', 4049: 'DT', 4050: 'Stewart', 4051: 'Perry', 4052: 'Pratley', 4053: '7867', 4054: 'Kendall', 4055: '#', 4056: 'Miami', 4057: 'FL', 4058: '33156', 4059: 'peternweissman', 4060: 'att', 4061: 'A21Gly', 4062: 'B31Arg', 4063: 'B32Arg', 4064: '222', 4065: '779', 4066: 'located', 4067: '504', 4068: 'declined', 4069: '0086', 4070: '0377', 4071: 'Albiglutide', 4072: 'NCT00838916', 4073: 'planned', 4074: 'GlaxoSmithKline', 4075: '25208756', 4076: '1094', 4077: 'db12', 4078: '0923', 4079: 'Smushkin', 4080: 'Sathananthan', 4081: 'Piccinini', 4082: 'Dalla', 4083: 'Man', 4084: 'Law', 4085: 'Cobelli', 4086: 'Zinsmeister', 4087: 'AR', 4088: 'Rizza', 4089: 'Vella', 4090: 'Mayo', 4091: 'Rochester', 4092: 'Minnesota', 4093: 'designed', 4094: 'experiment', 4095: 'sequestration', 4096: 'do', 4097: 'so', 4098: 'disposition', 4099: 'DI', 4100: 'Thirty', 4101: 'triple', 4102: 'tracer', 4103: 'mixed', 4104: 'Meal', 4105: 'Ra', 4106: 'EGP', 4107: 'Rd', 4108: 'β-', 4109: 'responsivity', 4110: 'then', 4111: 'calculate', 4112: '145', 4113: 'absence', 4114: 'Minimal', 4115: 'integrated', 4116: '191', 4117: '204', 4118: '817', 4119: 'suggesting', 4120: 'splanchnic', 4121: 'PMC3609563', 4122: '23250357', 4123: '258', 4124: '266', 4125: 'dc17', 4126: '0417', 4127: 'Weekly', 4128: 'Semaglutide', 4129: 'ER', 4130: 'SUSTAIN', 4131: 'Label', 4132: 'Ahmann', 4133: 'Capehorn', 4134: 'Charpentier', 4135: 'Dotta', 4136: 'Henkel', 4137: 'Lingvay', 4138: 'Holst', 4139: 'Annett', 4140: 'Harold', 4141: 'Schnitzer', 4142: 'OR', 4143: 'ahmanna', 4144: 'Rotherham', 4145: 'Clifton', 4146: 'Sud', 4147: 'Francilien', 4148: 'Corbeil', 4149: 'Essonnes', 4150: 'Surgery', 4151: 'Neuroscience', 4152: 'Siena', 4153: 'TU', 4154: 'Departments', 4155: 'Plainsboro', 4156: 'MedStar', 4157: 'semaglutide', 4158: 'extended', 4159: '3a', 4160: '813', 4161: 'indicate', 4162: '29246950', 4163: '321', 4164: '329', 4165: 'jdi', 4166: '12585', 4167: 'Bao', 4168: 'Hu', 4169: 'Peng', 4170: 'Jia', 4171: 'Sixth', 4172: 'Shengjing', 4173: 'Shenyang', 4174: 'Soochow', 4175: 'Suzhou', 4176: 'affiliated', 4177: '467', 4178: 'Randomization', 4179: 'asymptomatic', 4180: 'Neither', 4181: 'bodyweight', 4182: 'Sharp', 4183: 'Dohme', 4184: 'Corp', 4185: 'Journal', 4186: 'Investigation', 4187: 'AASD', 4188: 'PMC5415484', 4189: '27740719', 4190: '679', 4191: '0366', 4192: 'pharmacokinetics', 4193: 'pediatric', 4194: 'Klein', 4195: 'DJ', 4196: 'Battelino', 4197: 'Chatterjee', 4198: 'Jacobsen', 4199: 'LV', 4200: 'Hale', 4201: 'Arslanian', 4202: 'NN2211', 4203: '1800', 4204: 'De', 4205: 'Schepper', 4206: 'Barrett', 4207: 'Bone', 4208: 'Randell', 4209: 'Blumer', 4210: 'Christensen', 4211: 'Ferry', 4212: 'Hazan', 4213: 'Neufeld', 4214: 'Toltzis', 4215: 'Tsalikian', 4216: 'Wadwa', 4217: 'RP', 4218: 'Wintergerst', 4219: 'Cincinnati', 4220: 'Children', 4221: 'youth', 4222: 'old', 4223: 'Youth', 4224: 'having', 4225: 'escalated', 4226: 'equivalent', 4227: 'Nineteen', 4228: 'Transient', 4229: 'escalation', 4230: 'pancreatitis', 4231: 'lipase', 4232: 'elevations', 4233: 'calcitonin', 4234: 'life', 4235: 'decline', 4236: '9703', 4237: 'pharmacokinetic', 4238: 'PMC4183917', 4239: '25036533', 4240: '260', 4241: 'Initiating', 4242: 'analogs', 4243: 'Lewin', 4244: 'Gabbay', 4245: 'Garber', 4246: 'INITIATE', 4247: 'philip', 4248: 'raskin', 4249: 'utsouthwestern', 4250: '494', 4251: '1537', 4252: '1538', 4253: '550', 4254: 'initiated', 4255: 'directed', 4256: '209', 4257: 'Minor', 4258: '15677776', 4259: '2887', 4260: '03007990903354674', 4261: 'RCT', 4262: 'Bebakar', 4263: 'WM', 4264: 'Khutsoane', 4265: 'Pesic', 4266: 'Smahelov', 4267: 'Thomsen', 4268: 'HF', 4269: 'KSTROJEK', 4270: 'sum', 4271: 'pl', 4272: '480', 4273: 'NCT00469092', 4274: '433', 4275: 'Estimated', 4276: '029', 4277: 'experiencing', 4278: 'respect', 4279: 'fulfilled', 4280: '19821654', 4281: 'Fonseca', 4282: 'Staels', 4283: 'Morgan', 4284: 'JD', 4285: '2nd', 4286: 'Steinberg', 4287: 'Tulane', 4288: 'Orleans', 4289: '313', 4290: 'Incidences', 4291: '786', 4292: 'Two', 4293: 'assistance', 4294: '23116881', 4295: '2876', 4296: '2884', 4297: '13473', 4298: 'renal', 4299: 'insufficiency', 4300: 'CompoSIT', 4301: 'Scott', 4302: 'Zimmer', 4303: 'RLH', 4304: 'Raji', 4305: 'Lipid', 4306: 'Christchurch', 4307: 'glomerular', 4308: 'filtration', 4309: '73m2', 4310: 'longitudinal', 4311: 'NCT02532855', 4312: 'eGFR', 4313: 'incremental', 4314: 'review', 4315: 'notable', 4316: 'PMC6283039', 4317: '30019498', 4318: '1352', 4319: '03387', 4320: 'persons', 4321: 'Swallow', 4322: 'Llandough', 4323: 'Cardiff', 4324: 'Expert', 4325: 'Pharmacother', 4326: '1535', 4327: '1058', 4328: 'valuable', 4329: 'option', 4330: '21781152', 4331: 'BMC', 4332: 'Disord', 4333: 's12902', 4334: '0219', 4335: 'SH', 4336: 'Round', 4337: 'Latham', 4338: '2000', 4339: 'Galloping', 4340: 'Road', 4341: '07033', 4342: 'multiple', 4343: 'attaining', 4344: 'From', 4345: 'NCT01704261', 4346: 'Number', 4347: '002612', 4348: 'Date', 4349: 'PMC5674832', 4350: '29110647', 4351: '403', 4352: '12229', 4353: 'Del', 4354: 'Prato', 4355: 'Araga', 4356: 'broadly', 4357: 'bring', 4358: 'makes', 4359: 'attractive', 4360: 'failing', 4361: 'PMC4237555', 4362: '24199686'}\n","CONCLUSIONS\n","['CONCLUSIONS : Regardless of glycemic improvement , combination therapy of vildagliptin and metformin did not affect endothelial function but may exert favorable effects on adipokine levels and lipid profile in patients with type 2 diabetes without advanced atherosclerosis . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Body weight modestly increased with sitagliptin relative to placebo ( + 0 . 8 vs . - 0 . 4 kg ; p < 0 . 001 ) . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', '( 3 ) Audie L Murphy VA Hospital , San Antonio , Texas . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Riddle MC ( 1 ) , Rosenstock J , Gerich J ; Insulin Glargine 4002 Study Investigators . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'After 24 weeks , the difference in adjusted mean change in haemoglobin A1c ( HbA1c ) between vildagliptin and placebo was - 0 . 7 ± 0 . 1 % ( p < 0 . 001 ) in the overall study population , - 0 . 6 ± 0 . 1 % ( p < 0 . 001 ) in the subgroup also receiving metformin and - 0 . 8 ± 0 . 2 % ( p < 0 . 001 ) in the subgroup without metformin . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', '( 2 ) V . P . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Patients with HbA1c levels of 7 . 0 - 10 . 0 % on metformin and a maximum of one additional antidiabetes medication , which was discontinued at screening , continued on metformin ≥ 1500 mg / day for 6 weeks , including a placebo run - in period of 2 weeks , before being randomized to linagliptin 5 mg once daily ( n = 524 ) or placebo ( n = 177 ) add - on . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', '43 patients were administered metformin ( Tefor ICN Canada ) , and 46 patients were given placebo . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'DOI : 10 . 1007 / s00125 - 011 - 2382 - 3 PMID : 22134839 [ Indexed for MEDLINE ] <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Patients with T2DM aged 18 - 78 years with glycated hemoglobin ( HbA1c ) 7 . 5 - 11 % on a stable insulin regimen ( 30 - 150 U / day with or without metformin ) for ≥ 8 weeks at screening were included in the study . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'CONCLUSIONS : In patients with T2DM , inadequately controlled on OADs , once - daily insulin glargine plus glimepiride is effective in improving metabolic control with a reduced incidence of nocturnal hypoglycemia compared with NPH insulin . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'RESULTS : Exenatide treatment reduced hemoglobin A ( 1c ) level ( mean difference , - 0 . 98 % [ 95 % CI , - 1 . 21 % to - 0 . 74 % ] ) , serum fasting glucose level ( mean difference , - 1 . 69 mmol / L [ - 30 . 5 mg / dL ] [ CI , - 2 . 22 to - 1 . 17 mmol / L { - 40 . 0 to - 21 . 1 mg / dL } ] ) , and body weight ( mean difference , - 1 . 51 kg [ CI , - 2 . 15 to - 0 . 88 kg ] ) . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'BACKGROUND : Dipeptidyl peptidase - 4 ( DPP - 4 ) inhibitors may have protective effects in the early stage of atherosclerosis in patients with type 2 diabetes , although similar effects in advanced atherosclerosis were not shown in recent randomized placebo - controlled studies . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Horm Res . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Seventeen patients were randomized to 50 mg vildagliptin twice daily , and 16 to 100 mg sitagliptin once daily , and evaluated by continuous glucose monitoring at baseline and after 8 weeks . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Faster aspart demonstrated noninferiority versus IAsp in reducing HbA1c ( estimated treatment difference [ ETD ] [ 95 % CI ] - 0 . 02 % [ - 0 . 15 ; 0 . 10 ] ) . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'INTERVENTION : Patients were randomized to either placebo or acarbose 100 mg 3 times / day to be added to their metformin - vildagliptin regimen . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Changes in insulin sensitivity and insulin secretion with the sodium glucose cotransporter 2 inhibitor dapagliflozin . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Adjusted mean values for postprandial insulinaemia after therapy in the placebo group were lower as compared to the metformin group ( 44 . 807 mU / l vs . 47 . 114 mU / l ) . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', '( 17 ) Department of Internal Medicine , Inje University Busan Paik Hospital , Busan , Korea . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'DOI : 10 . 7326 / 0003 - 4819 - 154 - 2 - 201101180 - 00300 PMID : 21138825 [ Indexed for MEDLINE ] <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'The second group received placebo . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Comparative effects of vildagliptin and sitagliptin determined by continuous glucose monitoring in patients with type 2 diabetes mellitus . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', '2013 May ; 36 ( 5 ) : 1304 - 11 . doi : 10 . 2337 / dc12 - 0719 . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'DOI : 10 . 1111 / j . 1463 - 1326 . 2009 . 01173 . x PMID : 20092585 [ Indexed for MEDLINE ] <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Barnett AH ( 1 ) , Charbonnel B , Li J , Donovan M , Fleming D , Iqbal N . Author information : ( 1 ) Diabetes Centre , Heart of England National Health Service Foundation Trust and University of Birmingham , Birmingham , UK . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Diabetic Medicine © 2012 Diabetes UK . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', \"Wang W ( 1 ) , Ning G ( 1 ) , Ma J ( 2 ) , Liu X ( 3 ) , Zheng S ( 4 ) , Wu F ( 5 ) ( 6 ) , Xu L ( 5 ) , O ' Neill EA ( 5 ) , Fujita KP ( 5 ) ( 7 ) , Engel SS ( 5 ) , Kaufman KD ( 5 ) , Shankar RR ( 5 ) . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>\", 'Postmeal hypoglycemia ( 0 - 2 h ) rates were 2 . 27 ( faster aspart ) and 1 . 49 ( IAsp ) per patient - year of exposure ( RR [ 95 % CI ] 1 . 60 [ 1 . 13 ; 2 . 27 ] ) . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', '( 4 ) Department of Internal Medicine , National Health Insurance Service Ilsan Hospital , Goyang , Korea . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>', 'Durability of regimens will be evaluated in the following 2 - year maintenance phase . <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD> <PAD>']\n","torch.Size([32, 181, 36])\n","[[[], [], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], [], ['Author'], ['Author'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], ['TimePoint'], ['TimePoint'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], [], [], [], [], [], [], ['PvalueDiff'], ['PvalueDiff'], ['PvalueDiff'], ['PvalueDiff'], ['PvalueDiff'], [], [], [], [], [], [], [], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], [], [], [], [], [], [], ['PvalueDiff'], ['PvalueDiff'], ['PvalueDiff'], ['PvalueDiff'], ['PvalueDiff'], [], [], [], [], [], ['SubGroupDescription'], ['SubGroupDescription'], [], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], [], [], [], [], [], [], ['PvalueDiff'], ['PvalueDiff'], ['PvalueDiff'], ['PvalueDiff'], ['PvalueDiff'], [], [], [], [], ['SubGroupDescription'], ['SubGroupDescription'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['DoseValue'], [], [], [], [], [], [], ['NumberPatientsArm'], [], [], [], [], [], [], ['NumberPatientsArm'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], ['NumberPatientsArm'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['PMID'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition', 'MinAge'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], ['Precondition'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], [], [], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], [], [], [], [], [], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], [], [], [], [], [], [], [], [], [], [], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], [], [], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], ['ObjectiveDescription'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['Journal'], ['Journal'], ['Journal'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['NumberPatientsArm'], [], [], [], [], ['DoseValue'], [], [], ['Frequency'], ['Frequency'], [], [], ['NumberPatientsArm'], [], [], [], [], ['Frequency'], ['Frequency'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], ['DiffGroupAbsValue'], [], [], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], ['DoseValue'], [], ['Frequency'], ['Frequency'], ['Frequency'], ['Frequency'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['ResultMeasuredValue'], ['ResultMeasuredValue'], ['ResultMeasuredValue'], [], [], [], [], [], ['ResultMeasuredValue'], ['ResultMeasuredValue'], ['ResultMeasuredValue'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['PMID'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], ['Title'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['PublicationYear'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['PMID'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], [], ['Author'], ['Author'], [], ['Author'], ['Author'], [], ['Author'], ['Author'], [], ['Author'], ['Author'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], [], [], [], [], [], [], [], ['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], ['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], [], [], [], [], [], [], [], ['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], [], [], [], [], ['Author'], ['Author'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['SubGroupDescription'], ['SubGroupDescription'], [], [], [], [], [], [], [], [], ['ResultMeasuredValue'], ['ResultMeasuredValue'], ['ResultMeasuredValue'], [], [], [], [], [], ['ResultMeasuredValue'], ['ResultMeasuredValue'], ['ResultMeasuredValue'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], ['ConfIntervalDiff'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [[], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []], [['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], ['ConclusionComment'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], []]]\n","torch.Size([32, 181, 36])\n"]},{"output_type":"error","ename":"NameError","evalue":"ignored","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)","\u001b[0;32m/content/rnn.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m    224\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    225\u001b[0m \u001b[0;32mif\u001b[0m \u001b[0m__name__\u001b[0m \u001b[0;34m==\u001b[0m \u001b[0;34m\"__main__\"\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 226\u001b[0;31m     \u001b[0mmain_rnn\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mTRAIN_DATA_PATH\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mTEST_DATA_PATH\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m","\u001b[0;32m/content/rnn.py\u001b[0m in \u001b[0;36mmain_rnn\u001b[0;34m(train_file_path, test_file_path)\u001b[0m\n\u001b[1;32m    203\u001b[0m     \u001b[0;31m# 3. Execute the training loop\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    204\u001b[0m     \u001b[0;32mfor\u001b[0m \u001b[0mepoch\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mrange\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mconfig\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m\"epochs\"\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 205\u001b[0;31m         train_loss = train(\n\u001b[0m\u001b[1;32m    206\u001b[0m             \u001b[0mmodel\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mtrain_loader\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0moptimizer\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcriterion\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mdevice\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0midx_to_word\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0midx_to_label\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    207\u001b[0m         )\n","\u001b[0;32m/content/rnn.py\u001b[0m in \u001b[0;36mtrain\u001b[0;34m(model, iterator, optimizer, criterion, device, idx_to_word, idx_to_label)\u001b[0m\n\u001b[1;32m     72\u001b[0m         \u001b[0mpredictions\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mmodel\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0msentences\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     73\u001b[0m         \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mpredictions\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mshape\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 74\u001b[0;31m         \u001b[0mexit\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     75\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     76\u001b[0m         \u001b[0;31m# Compute loss\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;31mNameError\u001b[0m: name 'exit' is not defined"]}]},{"cell_type":"code","execution_count":null,"metadata":{"id":"88uINXGLEd9h"},"outputs":[],"source":["wandb.finish()"]},{"cell_type":"code","source":[],"metadata":{"id":"udAW-3-zQQMW"},"execution_count":null,"outputs":[]}],"metadata":{"accelerator":"GPU","colab":{"gpuType":"T4","provenance":[]},"kernelspec":{"display_name":"Python 3","name":"python3"},"language_info":{"name":"python"},"orig_nbformat":4},"nbformat":4,"nbformat_minor":0}